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ABSTRACT
Pathogenic bacterial infections are a serious threat to public health, claiming mil-
lions of lives every year. In order to contain the spread of infectious diseases sensitive
and timely diagnosis of pathogenic bacteria is of significant importance. The rapid
detection of low abundance analytes is still challenging in the most common bacte-
ria detection techniques including, culture and colony counting, Enzyme-linked Im-
munosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR). Conventional
bacteria detection techniques suffer from limitations such as low sensitivity, cost, long
procedural time and requiring complex lab equipment. Thus, there is a critical need
for rapid, sensitive and low-cost bacterial detection platform in various applications
ranging from water and food safety to medical diagnosis. The quest to overcome
these limitations have sparked significant interest in innovative biosensor develop-
ment, with considerable emphasis on optical techniques. Among optical biosensors,
label-free methods are highly desirable over label-based alternatives for eliminating
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the additional cost and sample processing required for labeling. Also, techniques
for whole-cell bacteria detection are preferred to detection of pathogenic molecular
components detection due to the requirement for extracting and isolating the desired
bacterial components such as nucleic acids or proteins. Overall, label-free whole-cell
detection of pathogenic bacteria has a significant advantage of simplicity in sample
preparation that translates to time and cost reduction.
An additional benefit of detecting whole-cell bacteria without labels, thus in their
natural environment, is the ability of monitoring the growth and replication of indi-
vidual pathogens with a potential application in antimicrobial susceptibility determi-
nation. Despite the significant advantages of antibiotics as one of our most powerful
tools for fighting infections, their extensive misuse and overuse over the years, have
resulted in the emergence of antibiotic resistant bacteria as the global health crisis
of our time. The current gold-standard technique for antibiotic susceptibility testing
(AST) used in clinics, is culture-based disk diffusion assays. The time-consuming
diagnosis method of the common clinical susceptibility testing, which is an inherent
limitation of culture-based techniques, have necessitated the need for an alternative
AST analysis platform. A clinical diagnosis test that could perform rapid pathogenic
bacteria identification and determine its susceptibility to a panel of selected antibi-
otics, would greatly reduce the hospital stay time for patients with bacterial infection,
therefore decreasing mortality and morbidity rate. In addition, it will have a great
economic impact on the global healthcare system by advising optimal antibiotic use
and maintaining the value of existing drugs.
In this dissertation, we describe the design and development of a rapid, sensitive,
and multiplexed biosensor platform that can both identify pathogenic bacteria and
perform image-based AST on a single reader instrument. The simple and low-cost de-
sign of our biosensing platform makes it a perfect candidate as a point-of-care (POC)
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diagnostic tool in clinical setting. The biosensor presented in this dissertation is based
on interferometric enhancement of the visibility of individual biological particles, such
as viruses and bacteria, afforded by Single Particle Interferometric Reflectance Imag-
ing Sensing (SP-IRIS), previously developed in our group. The integration of SP-IRIS
with microfluidic flow cells provides kinetic measurements capability, by enabling in-
liquid imaging of the sensor surface in real-time, therefore making it a promising
diagnostic platform. Here, we build upon the SP-IRIS platform and utilize it for
pathogenic bacteria identification and image-based AST analysis. To validate our
biosensor’s functionality, we demonstrate E. coli detection and characterization in
end-point and real-time measurement modality through particle detection and track-
ing analysis of the acquired images from sensor surface. In addition, we perform
rapid image-based AST analysis for E. coli bacteria against two antibiotics, ampi-
cillin and gentamicin, by monitoring single cell morphological variations and tracking




1.1 Background and motivation for bacteria detection . . . . . . . . . . . 1
1.2 Conventional bacteria detection techniques: An overview . . . . . . . 2
1.2.1 Culture and colony counting . . . . . . . . . . . . . . . . . . . 2
1.2.2 Polymerase Chain Reaction (PCR) . . . . . . . . . . . . . . . 3
1.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) . . . . . . . . 4
1.3 A brief survey of biosensors . . . . . . . . . . . . . . . . . . . . . . . 5
1.3.1 Electrochemical biosensors . . . . . . . . . . . . . . . . . . . . 6
1.3.2 Mechanical biosensors . . . . . . . . . . . . . . . . . . . . . . 7
1.3.3 Optical biosensors . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.4 Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS) 9
1.5 Overview of dissertation . . . . . . . . . . . . . . . . . . . . . . . . . 11
2 SP-IRIS for highly sensitive and label-free digital detection of whole
cell E. coli: End-point measurement 15
2.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2 Experimental protocol . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2.1 Preparation and quantification of bacterial samples . . . . . . 16
2.2.2 Sensor preparation . . . . . . . . . . . . . . . . . . . . . . . . 17
2.2.3 Sensor surface functionalization . . . . . . . . . . . . . . . . . 17
2.2.4 Microarray printing on sensor surface . . . . . . . . . . . . . . 18
2.2.5 E. coli detection experiment protocol in buffer and tap water . 19
ix
2.2.6 Well plate binding test . . . . . . . . . . . . . . . . . . . . . . 20
2.3 The optical setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.4 Sample imaging and analysis software . . . . . . . . . . . . . . . . . . 23
2.5 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.5.1 Statistical analysis of the sensor response . . . . . . . . . . . . 27
2.5.2 Calibration curve . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.5.3 Effect of increasing the sensor area on the assay sensitivity . . 32
2.5.4 Sensor specificity test . . . . . . . . . . . . . . . . . . . . . . . 34
2.5.5 Tap water calibration curve . . . . . . . . . . . . . . . . . . . 35
2.5.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3 SP-IRIS with DNA-Directed Antibody Immobilization for enhanced
detection of whole cell E. coli: Real-time measurement 42
3.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.2 Sensor surface capture efficiency enhancement . . . . . . . . . . . . . 43
3.2.1 Physical adsorption . . . . . . . . . . . . . . . . . . . . . . . . 43
3.2.2 Covalent attachment . . . . . . . . . . . . . . . . . . . . . . . 44
3.2.3 Affinity-based attachment . . . . . . . . . . . . . . . . . . . . 44
3.3 DDI utilization in SP-IRIS for E. coli detection . . . . . . . . . . . . 45
3.4 Experimental protocol . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.4.1 Sensor surface functionalization . . . . . . . . . . . . . . . . . 46
3.4.2 Antibody-DNA conjugation process . . . . . . . . . . . . . . . 47
3.4.3 Printing of biomolecules on sensor surface . . . . . . . . . . . 48
3.4.4 Bacterial sample preparation . . . . . . . . . . . . . . . . . . . 50
3.4.5 Fluorescence experiment for confirming DDI-based antibody
immobilization . . . . . . . . . . . . . . . . . . . . . . . . . . 50
x
3.4.6 IRIS Optical Setup and data Analysis for optimizing DDI-based
antibody immobilization . . . . . . . . . . . . . . . . . . . . . 52
3.4.7 Optical biosensor setup for real-time bacteria detection . . . . 53
3.4.8 Microfluidic chamber design . . . . . . . . . . . . . . . . . . . 54
3.4.9 Real-time particle detection and tracking analysis . . . . . . . 55
3.4.10 Bacteria capture on sensor surface assay procedures . . . . . . 56
3.5 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.5.1 Comparison of static and kinetic incubation for DNA-ab con-
jugate immobilization on sensor surface . . . . . . . . . . . . . 58
3.5.2 Heterogeneous DDI-based bacteria capture comparison for static
and kinetic incubation of DNA-ab conjugate . . . . . . . . . . 60
3.5.3 Homogeneous DDI-based real-Time bacteria capture and de-
tection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.5.4 Bacteria capture efficiency comparison for directly immobilized
and DNA-directed antibodies . . . . . . . . . . . . . . . . . . 67
3.5.5 End-point analysis for homogenous DDI-based bacteria detection 68
3.5.6 Bacteria capture efficiency comparison throughout the sensor
surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.5.7 antibody usage comparison for DNA-directed and direct immo-
bilization assays . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
4 Rapid image-based Antibiotic Susceptibility Testing (AST) assay
based on monitoring individual bacterial pathogens 75
4.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.2 Experimental protocol . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.2.1 Bacteria and antibiotic sample preparation . . . . . . . . . . . 77
xi
4.2.2 The optical setup requirement and modification for AST analysis 78
4.2.3 Heat transfer analysis in the fluid pathway . . . . . . . . . . . 80
4.2.4 Image analysis for bacteria growth rate estimation . . . . . . . 81
4.3 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 83
4.3.1 Cell surface area tracking throughout growth assay . . . . . . 83
4.3.2 Bacteria lag period estimation . . . . . . . . . . . . . . . . . . 84
4.3.3 Bacteria growth rate estimation . . . . . . . . . . . . . . . . . 85
4.3.4 Tracking bacteria growth and division cycles . . . . . . . . . . 86
4.3.5 Bacteria growth rate distribution . . . . . . . . . . . . . . . . 88
4.3.6 Antibiotic effect on growth rate and AST analysis . . . . . . 89
4.4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
5 Conclusions 93
5.1 Summary of the thesis . . . . . . . . . . . . . . . . . . . . . . . . . . 93
5.2 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
5.2.1 Microarray printing optimization for maximum target capture 95
5.2.2 microfluidic channel optimization . . . . . . . . . . . . . . . . 97
5.2.3 optical setup design improvement for high-throughput AST anal-
ysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98





2.1 Comparison of current study with other biosensors for whole-cell bacteria
detection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.1 DNA Sequences Used for Antibody Conjugation and Surface Probes. 48
4.1 antibiotic MIC levels for E. coli . . . . . . . . . . . . . . . . . . . . . 77
xiii
List of Figures
1·1 Schematics of the conventional pathogenic bacteria detection tech-
niques. (a) Culture and colony counting method. Reprinted from
(Aryal, 2019) (b) PCR. (c) ELISA. (d) ) Time series of the number
of works published on detection of pathogen bacteria. Reprinted from
(Lazcka et al., 2007) . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1·2 Diagram of biosensor working principle, comprising of three compo-
nents: detector, transducer and output system. Reprinted from (Said
and Azura, 2014). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1·3 (a) IRIS working principle based on the reflectance curve phase shift
as a result of biomass accumulation on layered substrate. (b) SP-
IRIS working principle based on interferometric enhancement of the
scattered light from the captured particles on layered substrate . . . . 10
2·1 Schematic of the bacterial sample preparation steps: (a) centrifuging
the E. coli in LB broth, reconstituting it in PBS and preparing the
serial dilutions. (b) Determining the original culture concentration
by OD600 measurements using a spectrophotometer. (Zaraee et al.,
2020a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2·2 Image of the culture plates from plating 100 µl of the two lowest con-
centrations of E. coli in PBS suspension. (Zaraee et al., 2020a) . . . . 17
xiv
2·3 Experimental protocol steps: incubating the spotted IRIS chips in 1ml
of E. coli dilutions in a well plate. The insets show the 10mm × 10mm
IRIS chips, which has been spotted with E. coli antibody (3.0 mg/ml)
and BSA (1.0 mg/ml) as negative control. (Zaraee et al., 2020a) . . . 19
2·4 Well plate binding test. Images of culture plate from two bacteria
sample concentrations of 2.17 × 102 CFU/ml and 2.17 × 103 CFU/ml
before, (a), and after, (b), 2-hour incubation in the well plate. (Zaraee
et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2·5 Schematic of the optical setup used for E. coli detection. The 4f system
propagates the LED light (at 525nm) to the beam splitter and the
objective. The scattered light from the substrate is focused through
the tube lens onto the CMOS camera. The zoomed-in inset shows the
schematic of an IRIS chip consisting of layered Si/SiO2 substrate with
an E. coli bacterium captured on the antibody spotted region. (Zaraee
et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2·6 Particle detection MATLAB algorithm step by step functionality pro-
cess. The arrows labeled 1,2 and 3 correspond to steps: 1. Registering
and scanning the antibody and BSA spots in each IRIS chip surface
image. 2. Detection of the captured particles on the sensor surface in
low-magnification images, through the initial size and intensity param-
eters entered by the user 3. Feedback loop to step 2 for optimizing the
detection parameters to count only the E. coli bacteria based on the
size and shape of the captured particles in chip’s high-magnification
images. (Zaraee et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . 24
xv
2·7 (a)-(e) Low- and high-magnification images of antibody spots, con-
firming the detected particles in low-magnification images, shown with
the green circle around them, by shape characterization in the high-
magnification images. (f) Comparison of analyzed images of the same
antibody spot, in pre and post incubation stages, to prevent false pos-
itive, shown with red circle. The red circle indicates the particles de-
tected at the same pixel location in pre and post incubation images.
(Zaraee et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2·8 (a)-(b). Left panels show one field of view of the low-magnification
imaging modality for two IRIS chips incubated in E. coli concentra-
tions of 3.2 × 104 CFU/ml and 3.2 × 10 CFU/ml, respectively. The
blue and green squares show two sample antibody spots to perform
shape and size characterization. The right panels show zoomed-in low-
magnification images (the bottom row) of these two antibody spots and
their corresponding high-magnification images (the top row) resolving
rod-shaped E. coli bacterium. (Zaraee et al., 2020a) . . . . . . . . . . 28
2·9 Histogram count of antibody spots on 4 different IRIS chips based
on the number of captured bacteria particles on each antibody spot.
The bar plots with colors blue, yellow, green and purple correspond
respectively to E. coli sample concentrations of 3.2 × 10 CFU/ml to 3.2
× 104 CFU/ml, shown with C1 to C4. The color-coded line plots show
the Poisson distribution fits corresponding to each histogram count,
confirming the independency of each binding event from one another.
(Zaraee et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
xvi
2·10 (a) Semi-log plot of the average particle counts per mm2 for antibody
(blue squares) and BSA spots (orange circles) on the IRIS chips based
on the E. coli concentration in PBS buffer. The standard deviation of
the counts is shown as an error bar for each concentration. The inset
shows the zoomed-in section of the same plot for the blank sample and
the first two E. coli concentrations. (b) log–log plot of the average
particle counts per mm2 for antibody spots based on the E. coli con-
centration in PBS buffer. The dashed black line shows the linear fit
to the data points, with a correlation of R2 = 0.93 to linear regression
equation of y = 0.46 x + 0.25. (Zaraee et al., 2020a) . . . . . . . . . 31
2·11 LOD per mm2 based on different sensor sizes, shown with black square
data points. The red solid line shows the non-linear fitting to the data
points with the equation y = 23.32 x-0.59 + 1 and a great correlation
of R2 = 0.99. (Zaraee et al., 2020a) . . . . . . . . . . . . . . . . . . . 33
2·12 Bar plot of average particle counts per antibody spot for IRIS chips
incubated in target bacteria E. coli and non-target bacteria S. aureus,
K.pneumonia and P. aeruginosa at 104 CFU/ml. The standard devia-
tion of the particle counts is shown as the error bars for each bacteria
type. (Zaraee et al., 2020a) . . . . . . . . . . . . . . . . . . . . . . . 34
xvii
2·13 (a) Semi-log plot of the average particle counts per mm2 for antibody
(blue squares) and BSA spots (orange circles) on the IRIS chips based
on the E. coli concentration in spiked tap water samples. The standard
deviation of the counts is shown as an error bar for each concentration.
The inset shows the zoomed-in section of the same plot for the blank
sample and the first two E. coli concentrations. (b) log–log plot of the
average particle counts per mm2 for antibody spots based on the E.
coli concentration in spiked tap water samples. The dashed black line
shows the linear fit to the data points, with a correlation of R2 = 0.89
to linear regression equation of y = 0.34 x + 0.41. (Zaraee et al., 2020a) 36
3·1 Image of the sensor surface showing microarray spotting schematics. . 49
3·2 Bacteria sample preparation and quantification schematics. . . . . . . 51
3·3 Fluorescent detection of DNA-directed antibody immobilized on DNA-
coated IRIS chip. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3·4 (a) Optical biosensor setup design for real-time bacteria detection uti-
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1.1 Background and motivation for bacteria detection
Bacteria are single-celled microorganisms, characterized by lack of a nuclear mem-
brane, which are to be the first organisms to appear on earth (Levin and Angert,
2015). Although they seem to have a simple structure, they are sophisticated and
have a significant capability to be highly adaptable to different environmental condi-
tions (bar, 1996). Bacteria are ubiquitous and can be found abundantly in various
environments such as human body, water, food and soil (Kidd, 2011). Only 5% of
the bacterial population are pathogenic and many nonpathogenic bacteria are in fact
beneficial to humans.
Despite their percentage, pathogenic bacterial infections and contaminations are
a serious threat to public health, claiming millions of lives every year. Contaminated
food and water are one of the most frequent causes of bacterial infections and their
rapid spread among consumers. Among foodborne pathogens, bacteria are the first
major cause (64%) of hospitalizations, and the leading cause (64%) of deaths (Scallan
et al., 2011). As reported by World Health Organization (WHO) in a 2015 study,
consuming contaminated food causes around 550 million people - almost 1 in 10
people in the world - to fall ill and an estimated 420,000 fatalities annually (WHO,
2015).
In addition, waterborne diarrheal diseases are estimated to be responsible for
2 million deaths each year, with the majority occurring in children under 5 years
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old (WHO, 2017). The mortalities from bacterial infections are particularly high in
developing countries among more vulnerable populations including children, elderly
and patients with poor medical conditions. Healthcare-Associated Infections (HAI) is
another source of bacterial infection which include those that patients acquire while
receiving health care. The US Center for Disease Control and Prevention (CDC)
identifies that HAIs occur in nearly 1.7 million hospitalized patients annually and
that more than 98,000 patients (one in 17) die due to these infections (Klevens et al.,
2007).
Sensitive and timely diagnosis of pathogenic bacteria is a determining factor in
minimizing the spreading of infectious diseases and enhancing the survival rates
(Lazcka et al., 2007). Therefore, there is a critical need for systems capable of detect-
ing bacteria in various applications ranging from water and food safety to medical
diagnosis.
1.2 Conventional bacteria detection techniques: An overview
The most conventional pathogenic bacteria detection methods include: (i) Culture-
based methods, (ii) molecular tests such as polymerase chain reaction (PCR) and (iii)
immunological tests such as enzyme-linked immunosorbent assays (ELISAs) (Ahmed
et al., 2014; Nurliyana et al., 2018; Rajapaksha et al., 2019). These techniques are
schematically described in figure 1·1a-c.
1.2.1 Culture and colony counting
The conventional culture and colony counting methods are based on visual inspections
of bacterial colonies formed from growing bacteria on nutrients in optimal conditions.
The bacteria detection process using this technique is performed as follows: (1) The
agar plate is covered with the diluted test sample, and incubated at the optimal tem-
perature for several hours to days (depending on the bacteria type) so that individual
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bacterial cells multiply and produce visible colonies on the plate. (2) The next day,
the formed colonies on the plate are counted, to get the number of present bacteria in
the diluted sample in units of colony-forming units per millilitre (cfu/ml) and finally
adjust it back to the bacteria concentration in the original undiluted sample.
However, despite their advantages such as reliability, accuracy, and versatility,
these techniques are inherently labor-intensive and very time-consuming (up to 72
hours are required to obtain confirmed results depending of the microorganisms)
(Lazcka et al., 2007; Velusamy et al., 2010).
1.2.2 Polymerase Chain Reaction (PCR)
PCR is a nucleic acid amplification technique which detects the target by isolation,
amplification and quantification of a DNA sequence, carrying the target’s genetic ma-
terial information (Garibyan and Avashia, 2013). The PCR detection process includes
3 main steps; (1) Denaturation, (2) Primer annealing and (3) Primer extension.
The denaturation includes separating the target DNA into two pieces of single-
stranded DNA using thermal cycling. The second step is annealing the primer, typi-
cally artificially designed oligonucleotides, to each original DNA strand for new strand
synthesis which results in the duplication of the original DNA. Finally, the extension
of the new DNA strands from the primers is performed by enzymatically replicating
the primer-bound sequences. These cycles are repeated continuously leading to more
than one billion exact copies of the original DNA segment (Coleman and Tsongalis,
2005).
The PCR technique has been used widely in bacteria detection due to its advan-
tages in its precision, fast detection and sensitivity (Fedio et al., 2011; Madic et al.,
2011). However, this technique presents its own challenges such as high cost, requir-
ing special facilities and high expertise in molecular biology, requiring pure samples
due the techniques’s high sensitivity (Law et al., 2015). add a table to summarize the
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advantage and disadvantage of three methods.
1.2.3 Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA methods detect the presence of the target analyte based on a visible color
change of the sample solution, produced by a chromogenic reporter which can be an
enzyme, a fluorescent or phosphorescent dye. This method is based on the ‘sandwich’
assay which includes specific binding of the target analyte to the capture antibodies
covering the wells of a microtiter plates, followed by the binding of the secondary an-
tibody conjugated with reporter enzyme, to the target analyte which in turn produces
visual results (Zourob et al., 2008; Shen et al., 2014).
The specificity and the sensitivity of ELISA methods depend on the binding
strength of the antibody specific to its antigens (Zhao et al., 2014). The major
drawbacks of ELISA methods are their requirements for many reagents and large
amounts of antibodies, high costs of antibody production to achieve high specificity
towards target bacteria, expensive lab equipment and potential non-specific reactions
producing false positive (Ahmed et al., 2014).
Due to limitations of conventional bacteria detection techniques, there is a crucial
need for rapid, sensitive and low-cost bacterial detection methods with minimal sam-
ple preparation. This has led to extensive research in developing biosensors for bacte-
rial detection in recent years (Lazcka et al., 2007). As shown in figure 1·1d, biosensors
have been the fastest growing technology for pathogen detection, confirmed by the
increasing number of publications focusing on the biosensor developments compared





Figure 1·1: Schematics of the conventional pathogenic bacteria detec-
tion techniques. (a) Culture and colony counting method. Reprinted
from (Aryal, 2019) (b) PCR. (c) ELISA. (d) ) Time series of the num-
ber of works published on detection of pathogen bacteria. Reprinted
from (Lazcka et al., 2007)
1.3 A brief survey of biosensors
A biosensor is an analytical device which transforms a biological response into a mea-
surable signal. The first and most widely used commercial biosensor is the glucose
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biosensor, which was developed by Leland C. Clark, known as the ‘father of biosen-
sors’, in 1962. This biosensor was based on oxygen electrode or ‘Clark electrode’,
developed by Clark in 1956 for oxygen detection (Heineman and Jensen, 2006).
biosensors consist of a bioreceptor element which recognizes the target analyte, a
transducer for translating the target recognition event into a measurable signal and
an output system to read the output signal, as shown schematically in diagram of
figure 1·2. Biosensors can be classified either based on their transducer signal type
(mechanical,electrochemical, or optical) or by their bioreceptor element type (anti-
body, aptamer, lectin, bacteriophage, or enzyme). Biosensors have been employed
for detection of various analytes with different sizes, ranging from small molecules to
nucleic acid and proteins up to whole bacteria and viruses (Rushworth et al., 2013).
In the case of biosensors developed for bacteria detection, they can be categorized
to two classes: (i) those detecting target bacterial components, such as DNA, RNA or
enzyme (Anderson et al., 2013; Foudeh et al., 2014; Miranda et al., 2011; Paniel and
Baudart, 2013) which require sample processing for bacterial disruption to release
the desired components, and (ii) those detecting whole bacteria which require no
sample processing. The additional time and cost required for sample processing and
extra reagents in the first category is a major drawback which makes whole bacteria
detection a more desirable technique for rapid and cost-effective testing. Therefore,
here we focus on biosensors capable of detecting whole bacteria. There are three major
categories of biosensors based on their transducer type: electrochemical, mechanical,
and optical.
1.3.1 Electrochemical biosensors
Electrochemical biosensors convert the interactions between the target analyte and
the bioreceptor element, conjugated to the sensor electrode interface, into measurable
electrical signals (Ghindilis et al., 1998). The target analyte detection is achieved by
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Figure 1·2: Diagram of biosensor working principle, comprising of
three components: detector, transducer and output system. Reprinted
from (Said and Azura, 2014).
measuring the changes of current, potential and impedance in electrode structures
(Grieshaber et al., 2008). Based on the measured parameter, electrochemical biosen-
sor can be divided into three categories: amperometric (current), potentiometric (po-
tential), and impedimetric (impedance) (Arora et al., 2011; Sharma and Mutharasan,
2013).
In general in most cases the elechtrochemical biosensors have major drawback since
they require either an enzyme label for improving the detection sensitivity, or involve
indirect target detection through a secondary reaction with an enzyme(Pejcic et al.,
2006). In addition, the dependence of the detection sensitivity on ion concentration
of the solution in conductance-based measurements limit their application for clinical
purposes(Yurt et al., 2012).
1.3.2 Mechanical biosensors
Mechanical biosensors are mass sensitive systems in which the transduction is based
on the small changes in mass. The two main categories of mechanical biosensors are
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quartz crystal microbalance (QCM) or cantilever technology (Ahmed et al., 2014).
QCM sensors are label-free piezoelectric biosensors, where the binding of the target
analyte to the bioreceptor functionalized piezoelectric sensor results in increased mass
on quartz crystal and therefore decrease of its oscillation frequency (O’Sullivan and
Guilbault, 1999).
Microcantilever sensor technology is another type of mechanical biosensor and the
working principle of these sensors is detecting the changes in the resonant frequency of
the cantilever due to induced mechanical bending as a result of increase in mass (ana-
lyte binding) on the functionalized microcantilever surface (Lang and Gerber, 2008).
Mechanical biosensors don’t operate properly in liquid or air due to viscosity losses,
resulting in low quality factor. Therefore, a critical drawback of these biosensors is
that they require vacuum condition for sensitive measurement(Davila et al., 2007),
hindering their applicability as a point of care (POC) diagnostic tool. In addition,
for QCM sensors to generate a detectable signal, a biomass of the antigen should be
present on the sensor surface, therefore limiting its sensitivity for single biological
target detection(Hwang et al., 2009).
1.3.3 Optical biosensors
Optical biosensors are the most promising technologies for whole bacteria detection
which operate based on extracting target binding-induced changes in the optical prop-
erties of the sensor surface. The most commonly studied optical biosensors for whole
bacteria detection can be divided to two main categories: (i) Fluorescence-based sen-
sors. (ii) Label-free sensors such as Surface Plasmon Resonance (SPR)(Zaraee et al.,
2020b).
Fluorescence-based sensors rely on secondary fluorescently labeled reagents bind-
ing to captured bacteria on the sensor surface. Similar to other label-based detection
techniques, the additional time and cost required for the fluorescent labeling step
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in these biosensors limits their application in rapid target analyte detection(Ahmed
et al., 2014). One other drawback of label-based detection technique is that labeling
of the detection antibodies may interfere with their binding sites which can change
their interaction with the analyte. Finally, in addition to photobleaching problem of
the fluorescent label which limits the available observation time, nonspecific binding
of the fluorescent labels in complex media may results in false positive signal in these
biosensors(Moerner and Fromm, 2003).
SPR biosensors detect the refractive changes in the vicinity of a thin film metal
surface due to binding of the target to the receptors immobilized on the sensor sur-
face. The early types of SPR-based biosensors suffered from low sensitivity, especially
for detection of whole bacteria, due to similar refractive index of bacteria with the
surrounding and also small penetration depth of the electromagnetic field into the
bacteria(Yoo and Lee, 2016; Ahmed et al., 2014).
In recent years, various strategies have been introduced to improve the sensitivity
level of SPR biosensors such as long-range SPR and Surface-enhanced Raman scat-
tering (SERS). However, SPR biosensors in general are complex, expensive and large
equipment and therefore not suitable for a POC diagnostic tool(Zaraee et al., 2020b).
Moreover, these sensors require special sample purification and handling and suffer
from interference of non-specific surface binding.
1.4 Single Particle Interferometric Reflectance Imaging Sen-
sor (SP-IRIS)
The optical biosensor developed in our group, named Interferometric Reflectance
Imaging Sensor (IRIS) offers a simple reflectance-based interferometric label-free de-
tection method. Earlier applications of IRIS included ensemble measurements of
biolayer height increase due to the accumulated biomass on the functionalized sen-
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sor surface(Daaboul et al., 2011; Lopez et al., 2011). In this technique the layered
Si/SiO2 sensor surface acts as a common-path interferometer by detecting the optical
path difference (OPD) as a result of biomass accumulation on the surface (Avci et al.,
2015). IRIS has been shown to be a versatile platform for high-throughput detection
of antigen–antibody, DNA-protein binding and DNA-DNA hybridization(Avci et al.,
2015; Ozkumur et al., 2010).
(a)
(b)
Figure 1·3: (a) IRIS working principle based on the reflectance curve
phase shift as a result of biomass accumulation on layered substrate.
(b) SP-IRIS working principle based on interferometric enhancement
of the scattered light from the captured particles on layered substrate
The second modality of this biosensor called Single Particle IRIS (SP-IRIS) is
capable of detecting single biological particles such as whole virus(Daaboul et al.,
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2014; Scherr et al., 2016; Seymour et al., 2015), exosomes(Daaboul et al., 2016)
and proteins(Monroe et al., 2013). The interferometric enhancement of the scattered
light from the captured target on the layered substrate in SP-IRIS offers a sensitive,
high-throughput and multiplexed platform for single particle detection. In addition,
the integration of SP-IRIS with microfluidic channels provides kinetic measurements
capability, therefore making it a promising diagnostic platform.
1.5 Overview of dissertation
The primary goal of this dissertation is design and development of a rapid, sensitive,
and multiplexed sensor platform that can perform both pathogenic bacteria identi-
fication and characterization, and antibiotic susceptibility testing (AST) on a single
reader instrument. The prevalent bacterial infection outbreaks even in developed
countries such as united states, and the emergence of resistant bacteria as the global
health crisis of our time, have necessitated the need for a cost-effective, rapid and
sensitive bacteria detection and AST analysis platform. We believe the outcome of
this study could be a significant improvement as a point-of-care POC diagnostic tool
in clinical setting compared to the time-consuming culture-based methods currently
practiced in clinics. A clinical test that could both identify a pathogen and determine
its susceptibility to a panel of selected antibiotics in a timely manner would greatly
reduce the hospital stay for the patients with bacterial infection, therefore decreasing
their mortality and morbidity rate. In addition, it will significantly decrease the eco-
nomic burden on the global healthcare system, as a result of the resistant bacterial
infections, by advising optimal antibiotic use and maintaining the value of existing
drugs. The biosensor platform presented in this thesis in mainly based on the Single
Particle Interferometric Reflectance Imaging Sensing (SP-IRIS), previously developed
in our group.
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Chapter 2 describes the design and implementation of a rapid, label-free and
cost-effective optical biosensor for end-point detection of whole-cell E. coli based on
SP-IRIS. We present here a dual imaging modality of our developed optical biosensor
to perform both target detection (first modality with low magnification objective) and
morphological characterization (second modality with high magnification objective)
by switching between these modalities. We then provide a detailed description of our
particle detection MATLAB algorithm to acquire the average number of captured
target cells on our sensor surface. The functionality of our biosensor is demonstrated
by specific detection of E. coli both in buffer and tap water. In addition, we investi-
gate the specificity of this biosensor for E. coli detection, by testing it against three
other pathogenic bacteria S. aureus, K. pneumonia and P. aeruginosa. The label-free
capture and detection technique described here is advantageous in terms of no sam-
ple pre-processing or modification requirement, compared to the techniques detecting
bacterial molecular components.
In chapter 3, we improve upon our end-point bacteria detection results presented
in chapter 2, for real-time in-liquid bacteria detection which will decrease the detec-
tion assay significantly and eliminate the requirement for the user to directly operate
the sensor incubation and washing steps. We first discuss the implemented design im-
provements to utilize our biosensor as a POC diagnostic tool. The first improvement
is integrating our biosensor with a disposable microfluidic channel, enabling in-liquid
imaging of the senor surface during bacteria detection assay. The second improvement
is regarding the sensor surface capture efficiency enhancement to improve the sensi-
tivity and robustness of our biosensor platform. We initially discuss the three general
categories of surface chemistry used for antibody immobilization on glass surface,
and the advantages of affinity-based attachment techniques. To implement this sur-
face chemistry technique to our biosensor, we employ DNA Directed Immobilization
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(DDI) of antibody for capturing the target analyte instead of direct antibody immo-
bilization. The third improvement is modifying our optical setup design by optimized
combination of the camera sensor and the imaging objective to acquire a large FOV
with single-cell level resolution simultaneously. This will decrease our bacteria detec-
tion assay time compared to the end-point detection assay which required two-step
imaging for both detection and target shape characterization. We then demonstrate
our biosensor’s enhanced functionality by performing both heterogeneous and homo-
geneous DDI-based E. coli detection and compare its capture efficiency to the directly
immobilized antibody spots in our printed microarray on sensor surface.
In chapter 4, we expand the applications of our developed optical biosensor in
real-time imaging modality, as a rapid, sensitive, low-cost and user-friendly AST tool
in clinical settings. Although AST analysis was not the primary goal of this disser-
tation, our acquired preliminary results show high-level promise for our biosensor’s
application in AST analysis. In this chapter, we discuss 1) the emergence of the re-
sistance bacterial infections as a global health crisis of our era, 2) the common AST
techniques which are currently practiced in clinics such as disk diffusion assay, 3) The
shortcoming of culture-based AST techniques in providing timely test result for the
doctors to make an informed decision on antibiotic prescription. We next introduce
the key advantages of our biosensor as a rapid image-based AST tool by monitoring
single cell morphological changes and tracking their growth rate under various antibi-
otic challenges. Performing the AST analysis was feasible by modifying our fixture
and the IRIS chip holder design to incorporate the heating element inside, therefore
providing optimal temperature for bacteria growth in the fluid chamber. In addition,
we provide a step-by-step description of our custom-developed image analysis MAT-
LAB algorithm for monitoring cell surface area. Lastly, our biosensor’s performance
for rapid susceptibility testing is demonstrated for two antibiotics, ampicillin and
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gentamicin, against E. coli bacteria.
Finally, an outlook of the dissertation and the potential future directions for this
study; in microarray printing optimization, microfluidic channel, and optical setup
design modifications; is presented in chapter 5.
Each of these chapters begin with a motivation section and ends with a summary
of the results presented in that chapter. In this Introduction we have included the
motivation behind this dissertation, as well as the required background concepts for a
better understanding of the entire dissertation. We first discuss the most conventional
pathogenic bacteria detection techniques and their limitations which necessitates the
research efforts for developing a biosensor to addresses those limitations. In the next
section, we provide a brief survey of different biosensing techniques, their working
principle and shortcomings. Next, we focus on the optical biosensors which have
proven to be the perfect candidate for label-free and sensitive whole-cell bacteria
detection. Finally, we briefly discuss the working principle of the two main modality
of the biosensor previously developed in our group, for ensemble measurements (IRIS)
and single particle detection (SP-IRIS).
15
Chapter 2
SP-IRIS for highly sensitive and label-free
digital detection of whole cell E. coli:
End-point measurement
2.1 Motivation
Bacterial infectious diseases are a major threat to human health. Timely and sensi-
tive pathogenic bacteria detection is crucial in identifying the bacterial contaminations
and preventing the spread of infectious diseases. Due to aforementioned limitations of
conventional bacteria detection techniques there have been concerted research efforts
towards development of new biosensors. Biosensors offering label-free, whole bacteria
detection are highly desirable over those relying on label-based or pathogenic molec-
ular components detection. The major advantage is eliminating the additional time
and cost required for labeling or extracting the desired bacterial components. Here,
we demonstrate rapid, sensitive and label-free E. coli detection utilizing interfero-
metric reflectance imaging enhancement allowing for visualizing individual pathogens
captured on the surface. In this chapter we describe the design and implementation
of an optical biosensor based on SP-IRIS for rapid and sensitive whole-cell bacteria
detection with end-point measurement modality.
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2.2 Experimental protocol
2.2.1 Preparation and quantification of bacterial samples
Genetically unmodified K-12 MG1655 (ATCC 47076) strain of E. coli was purchased
from ATCC. E. coli colonies were scraped from frozen stock and incubated overnight
in Luria-Bertani (LB) broth at 37 ◦C. After 14 hours of incubation, E. coli culture
was spun down at 13,000 rpm and 4 ◦C for 10 minutes and then reconstituted in
sterile Phosphate Buffered Saline (PBS). The reconstituted culture solution was se-
rially diluted in a 96-well plate and absorbance at 600 nm was measured using a
spectrophotometer to determine the starting concentration of bacterial culture, as
shown schematically in Figure 2·1b. The number of cells is directly proportional to
the OD600 measurements (1 OD600 = 108 CFU/mL). Tenfold serial dilution of the
culture solution was performed to obtain sample concentrations ranging from 107
CFU/ml to 10 CFU/ml, as described in Figure 2·1a.
(a) (b)
Figure 2·1: Schematic of the bacterial sample preparation steps:
(a) centrifuging the E. coli in LB broth, reconstituting it in PBS
and preparing the serial dilutions. (b) Determining the original cul-
ture concentration by OD600 measurements using a spectrophotome-
ter. (Zaraee et al., 2020a)
For the lower concentrations (103 CFU/ml, 102 CFU/ml), concentration of bac-
teria sample was also quantified by plating 100 µl of culture solution into separate
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LB-agar plates, followed by incubation at 37 ◦C for 12 hours and subsequently count-
ing individual colonies on each plate. The images of these culture plates are shown
in Figure 2·2.
Figure 2·2: Image of the culture plates from plating 100 µl of the
two lowest concentrations of E. coli in PBS suspension. (Zaraee et al.,
2020a)
2.2.2 Sensor preparation
Silicon wafers with thermally grown 110nm silicon dioxide layer were purchased from
Silicon Valley Microelectronics (Santa Clara, CA, USA) and cleaned by acetone son-
ication, DI water rinse and nitrogen drying. The next sections describe the sensor
surface functionalization for end-point E. coli detection experiments.
2.2.3 Sensor surface functionalization
The sensor chip consists of a layered Si/SiO2 substrate which is modified with MCP-4
(copoly DMA-NAS-MAPS) (Cretich et al., 2004), a polymer typically used to coat
glass, silicon, or other hydroxylated surfaces for microarray applications. The sur-
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face chemistry used to modify the substrate surface should meet the following re-
quirements: 1- availability of functional groups for probe attachment, 2- preventing
non-specific binding to the surface, 3- stability to environmental changes, 4- being
ideally low cost, robust and easily prepared (Cretich et al., 2006). Therefore, MCP-
4 copolymer from Lucidant Polymers (Sunnyvale, CA, USA) is used to immobilize
antibodies for E. coli detection in this study which is recommended for DNA and pep-
tide arrays. Each monomer forming the MCP-4 (copoly DMA-NAS-MAPS) copoly-
mer (Cretich et al., 2004) has a different function: dimethylacrylamide (DMA) en-
ables self-adsorption to the SiO2 substrate, 3- (trimethoxysilyl) propyl methacrylate
(MAPS) provides covalent binding to the substrate through silane functional groups,
and acryloyloxysuccinimide (NAS) presents NHS ester groups which are utilized in
biomolecule probe covalent immobilization. Therefore, MCP-4 is an ideal polymer for
antibody immobilization on the substrate used in this study. Polymer coating was
achieved through first, oxygen plasma treating the chips which forms hydroxylated
surface to adhere the polymer to the substrate; and second, incubation of the chips
in polymer solution for 30 minutes. After the incubation, the chips are rinsed with
DI water and kept under vacuum until used. The polymer coated chips can be stored
under vacuum for up to 6 months. The polymer coating exhibits functional groups
on the sensor surface which allows immobilization of antibodies of interest. The bind-
ing between the biomolecules and the solid surface during immobilization is strong
enough to retain the molecules on the surface during the entire biosensing experiment.
Moreover, the local chemical environment allows the immobilized molecules to retain
a native conformation and functionality after immobilization.
2.2.4 Microarray printing on sensor surface
The antibody (Anti- E. coli O + E. coli K antibody), purchased from Abcam (Cam-
bridge, MA, USA), was used to capture E. coli on the sensor at a concentration of
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3.0 mg/ml. A Scienion sciFLEXARRAYER S3 (Berlin, Germany) spotter instrument
was used to create an array of antibodies. This instrument provides a high precision
and accuracy in spotting thousands of spots on the chip surface with a user defined
pitch (300 µm in this study) between the spots and a droplet volume of 200 pL. The
periodicity of the spots and the humidity in the spotting chamber (set to 57%) were
optimized in order to prevent merging of neighboring spots. The chips were left in
the spotter chamber for 24 hours to allow time for the antibodies to immobilize on
the surface. In addition to the antibody, bovine serum albumin (BSA at 1.0 mg/ml)
was spotted on the same chips as a negative control in the experiments, shown in
Figure 2·3. The chips were then blocked for 1 hour in a buffer of 0.1 M Tris and 50
mM Ethanolamine (pH of 9) and then washed with DI water.
Figure 2·3: Experimental protocol steps: incubating the spotted IRIS
chips in 1ml of E. coli dilutions in a well plate. The insets show the
10mm × 10mm IRIS chips, which has been spotted with E. coli anti-
body (3.0 mg/ml) and BSA (1.0 mg/ml) as negative control. (Zaraee
et al., 2020a)
2.2.5 E. coli detection experiment protocol in buffer and tap water
The anti-E. coli antibody spotted IRIS chips are incubated in 1ml of E. coli dilutions
in PBS ranging from 10 CFU/ml to 106 CFU/ml. As shown in Figure 2·3 the incu-
bation is performed in a 24-wellplate on low speed shaker for 2 hours while the IRIS
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chip is resting at the bottom of each well at room temperature. In order to prevent
surface-attached microbial agglomerations, we added Tween-20, a non-ionic surfac-
tant, to each incubation well to a final concentration of 0.1%. Previous research has
shown the role of surfactants in inhibiting biofilm formation in gram-negative bac-
teria; Wu et al. specifically demonstrated disruption of biofilm formed by E. coli at
solid-liquid interface by Tween-20 (Mireles et al., 2001; Toutain-Kidd et al., 2009; Wu
et al., 2013). During the incubation period, whole E. coli cells are captured on the
IRIS chip surface by binding to corresponding surface-immobilized antibodies. The
chips are then taken out of the incubation well and washed three times in 1x PBS
solution for 1 minute on medium speed shaker before being air dried. The insets of
Figure 2·3 show the 10mm × 10mm IRIS chips, and a zoomed-in image of the chip
surface before incubation, which has been spotted with antibody for E. coli capture
and BSA as a negative control.
In order to show the applicability of the proposed bacteria detection method in
non-sterile, real matrices, we also performed the same experiment with tap water.
To keep the bacteria intact and the antibody spots on the IRIS chips activated, the
pH of the dilution sample is kept to 7.4 by preparing a base solution containing 9
parts tap water and 1 part 1x PBS. Next, the diluted tap water is spiked with E. coli
samples with concentrations ranging from 10 to 107 CFU/ml. The same incubation
procedure is performed by adding 1ml of each dilution sample and 0.1% Tween-20 to
each incubation well, placed at room temperature on medium speed shaker.
2.2.6 Well plate binding test
In addition, we performed control experiments to ensure that E. coli particles do not
bind to the interior surface of the well plate during the 2-hour incubation time. We
prepare two E. coli in PBS dilutions with concentrations of 2.17 × 102 CFU/ml and
2.17 × 103 CFU/ml by serially diluting the original stock concentration of 2.17 × 108
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CFU/ml. This concentration is obtained from absorbance measurement at 600nm
by a spectrophotometer/plate reader. The concentrations of these samples are also
quantified by plating 100 µl of culture solution into separate LB-agar plates, followed




Figure 2·4: Well plate binding test. Images of culture plate from two
bacteria sample concentrations of 2.17 × 102 CFU/ml and 2.17 × 103
CFU/ml before, (a), and after, (b), 2-hour incubation in the well plate.
(Zaraee et al., 2020a)
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The images of these culture plates are shown in Figure 2·4a, with 20 colony counts
in the left plate and 202 colony counts in the right plate. Next, we incubate 1ml of
each dilution sample into separate wells of our well plate located on a low-speed shaker
at room temperature for 2 hours. Figure 2·4b shows the images of culture plates from
plating a 100 µl sample of the two E. coli solutions in the well plate after the 2-hour
incubation,with 14 colony counts in the left plate and 184 colony counts in the right
plate.
2.3 The optical setup
As shown schematically in Figure 2·5, the IRIS chip surface is illuminated through a
Köhler illumination setup from an LED source at 520 nm wavelength. The illumina-
tion light is propagated by a 4f system to the beam splitter and the back focal plane
of the objective. The light reflected from the sample is then imaged on to a CMOS
camera through the tube lens. A 5X magnification and 0.15 numerical aperture (NA)
objective is used for imaging the chip surface. The CMOS camera has a 3.45 µm pixel
size chosen to ensure a diffraction-limited system as described in equation 2.1 relating
the minimum required pixel size (p) to the illumination wavelength (λ), magnification






We use a common path interferometric enhancement technique through a layered
substrate, consisting of a thermally grown silicon dioxide layer on top of a silicon
substrate, to enhance the visibility of the particles captured on the sensor surface
(Avci et al., 2016). The visibility enhancement is achieved through constructive
interference between the scattered light from the captured particles and the reflected
light from the substrate’s Si/SiO2 interface. The principle behind the interferometric
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enhancements in IRIS technology is a well-established method and has been Discussed
in great details in previous publications (Avci et al., 2015).
Figure 2·5: Schematic of the optical setup used for E. coli detec-
tion. The 4f system propagates the LED light (at 525nm) to the beam
splitter and the objective. The scattered light from the substrate is
focused through the tube lens onto the CMOS camera. The zoomed-in
inset shows the schematic of an IRIS chip consisting of layered Si/SiO2
substrate with an E. coli bacterium captured on the antibody spotted
region. (Zaraee et al., 2020a)
2.4 Sample imaging and analysis software
The low-magnification modality of our biosensor provides imaging of the IRIS chips by
a 5X magnification and 0.15 numerical aperture (NA) objective through the optical
setup shown in Figure 2·5, at the visible wavelength of 520 nm. One of the most
important advantages of this detection technique is the large field of view provided
by the 5X objective, around 5.85 mm2 (2.83 µm × 2.1 µm), which ensures a rapid
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scan of the entire IRIS chip for detection of the captured bacteria. We next perform a
rapid digital detection and counting of the captured particles on the chip surface, using
our custom-developed particle detection MATLAB algorithm, as shown schematically
in Figure 2·6. The image of the sensor surface taken with the low-magnification
modality is imported as the input of the algorithm, as shown in part (i). At the first
step, the user enters the pixel values corresponding to: 1- The pixel coordinates of
the left edge of first antibody spot on the top-left part of chip image and, 2- The
pixel pitch between two adjacent spots. Using the entered parameters, the algorithm
automatically registers and scans, one by one, the antibody and BSA spots on the
chip, as shown by step 1 in Figure 2·6.
Figure 2·6: Particle detection MATLAB algorithm step by step func-
tionality process. The arrows labeled 1,2 and 3 correspond to steps:
1. Registering and scanning the antibody and BSA spots in each IRIS
chip surface image. 2. Detection of the captured particles on the sen-
sor surface in low-magnification images, through the initial size and
intensity parameters entered by the user 3. Feedback loop to step 2
for optimizing the detection parameters to count only the E. coli bac-
teria based on the size and shape of the captured particles in chip’s
high-magnification images. (Zaraee et al., 2020a)
Next, for each antibody and BSA spot, the algorithm should detect and count
the captured bacteria particles which appear as a diffraction-limited spot in the low-
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magnification images (Figure 2·6, part (ii)) and save the total counts in a final array.
The basis of the particle detection algorithm is Scale-Invariant Feature Transform
(SIFT) which requires optimizing the size and intensity parameters in order for the
software to detect and count only the bacteria particles on the surface and prevent
false positive counts (Zaraee et al., 2020b). As shown in part (ii), in addition to
bacteria particles there are salt residue from the dried PBS solution on the antibody
spots which could cause a false positive in the final counts if the detection parameters
are not well optimized.
In addition to the chemical specificity provided by the antibody spots to specif-
ically capture the E. coli bacteria, shape and size characterization is also performed
through the high-magnification imaging modality of our sensor, as shown in part
(iii). We benchmarked the particle detection algorithm functionality against these
high-magnification images where the rod-shaped bacteria are clearly resolvable, con-
firming that the parameters have been well optimized to count only the E. coli par-
ticles. Therefore, the parameter optimization is achieved through a closed loop feed-
back, steps 2 and 3 of Figure 2·6, which compares the detected particles in the low-
magnification images to their corresponding high-magnification ones. The detection
parameters’ optimization is achieved by repeating the feedback loop only for a few an-
tibody spots on each IRIS chip for different bacteria sample concentrations, therefore
offering a rapid digital detection of the captured particles on our sensor surface.
Figure 2·7 validates the functionality of the particle detection algorithm by com-
paring the analyzed low-mag images of different spots with their corresponding high-
mag images. The left panels of parts (a)-(e) show the low-mag images of antibody
spots from IRIS chips which have been incubated in E. coli concentrations of 3.2
× (106, 104 to 101) CFU/ml. The green circles show the captured particles on the
antibody spots which have been detected and counted by the algorithm as the E. coli
26
bacterium. These detected particles are verified to be E. coli bacterium through shape
and size characterization, by comparing with the corresponding antibody spots’ high-
mag image, where each diffraction-limited dot appears as the rod-shaped particles,
confirming that the input detection parameters have been well optimized.
Figure 2·7: (a)-(e) Low- and high-magnification images of antibody
spots, confirming the detected particles in low-magnification images,
shown with the green circle around them, by shape characterization in
the high-magnification images. (f) Comparison of analyzed images of
the same antibody spot, in pre and post incubation stages, to prevent
false positive, shown with red circle. The red circle indicates the par-
ticles detected at the same pixel location in pre and post incubation
images. (Zaraee et al., 2020a)
In addition, a possible source of false positives in the particle detection algorithm
is the pre-existing particles on the chip surface before incubation such as small dust
particles. In order to account for these particles, we also image and analyze the IRIS
chips before incubation and compare with their analyzed after-incubation images, as
shown in Figure 2·7f. If a particle is recognized at the same pixel coordinates in both
pre and post incubation images, it is flagged as a false positive and will be removed
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from the final counts in the algorithm. The red circle in part (f) represent such false
positives in a sample IRIS chip, whereas the green circles represent the particles which
have been correctly detected and counted as E. coli.
2.5 Results and discussion
2.5.1 Statistical analysis of the sensor response
As discussed earlier, the dual imaging modality of our optical setup allows rapid scan
and analysis of the entire chip surface while enabling morphological characterization
and identification of the captured particles on the sensor surface, if so desired.
Figures 2·8a and 2·8b show one field of view of the low-magnification imaging
modality, for two IRIS chips incubated in medium (3.2 × 104 CFU/ml) and low (3.2
× 10 CFU/ml) bacteria sample concentrations. The blue and green squares show two
antibody spots which we have selected to perform high magnification characterization.
The right panels of figures 2·8a and 2·8b show a blow up of low-magnification images
(the bottom row) of these two antibody spots, along with corresponding images ac-
quired in high-magnification modality (the top row). Unlike the high-magnification
images where one can easily resolve the single rod-shaped captured E. coli particles,
they appear as diffraction-limited dots in the low-magnification images.
As shown in figure 2·8a, for the medium bacteria sample concentration, each
antibody spot on the chip has at least a few captured E. coli bacteria. In contrast,
in case of the lowest concentration, most of the antibody spots are blank as a direct
consequence of the number of antibody spots on the chip (here 220) exceeding the
total number of E. coli particles in the incubation sample.
Figure 2·9 histogram plot indicates the frequency of antibody spots in one field of
view of each IRIS chip based on the number of captured bacteria on each antibody
spot for varying concentrations of bacteria target solution. An excellent fit to a
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Poisson distribution at each concentration confirms that bacteria capture represents
independent events thus our detection modality would follow Poisson statistics.
(a)
(b)
Figure 2·8: (a)-(b). Left panels show one field of view of the low-
magnification imaging modality for two IRIS chips incubated in E. coli
concentrations of 3.2 × 104 CFU/ml and 3.2 × 10 CFU/ml, respec-
tively. The blue and green squares show two sample antibody spots
to perform shape and size characterization. The right panels show
zoomed-in low-magnification images (the bottom row) of these two an-
tibody spots and their corresponding high-magnification images (the
top row) resolving rod-shaped E. coli bacterium. (Zaraee et al., 2020a)
Therefore, a sampling of representative spots for verification through high mag-
nification imaging can lead to an accurate estimation of total number of captured
bacteria hence the concentration in the target solution. For example, at low concen-
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tration,only 6 spots out of 50 have any potential detection events. At a sampling rate
of 10%, one can validate nearly all detection events in high-magnification allowing
for an accurate estimation even in case of low number of events with the potential of
false positives.
In case of high concentrations, validating detection events on even fewer spots
selected to represent the distribution will provide sufficient sampling for accurate
estimation. Therefore, the burden of high-magnification imaging can be kept at a
minimum (only 10% or less of the spots are re-imaged) regardless of the sample
concentration and will improve the Limit Of Detection (LOD) by reducing the false
positives at low concentration.
2.5.2 Calibration curve
To obtain the calibration curve in our experiment for quantitative analysis of unknown
sample concentrations, we incubated IRIS chips with E. coli in PBS dilutions for
concentrations ranging from 3.2 × 10 to 106 CFU/ml. Figure 2·10a shows a semi-log
plot of the average particle count per mm2 for both antibody and BSA spots as a
function of E.coli concentration. An E. coli concentration of 0 in the plot corresponds
to blank PBS sample incubation.
Note that each antibody spot has a diameter of 160 µm, and therefore the area
of 50 antibody spots corresponds to 1 mm2 of a functionalized IRIS chip. To obtain
the average particle count per mm2, we first sum the particle counts on every 50
antibody spots and then obtain the average of the summations on each IRIS chip.
The standard deviations of all the summation counts on each chip is shown as error
bars for the corresponding sample concentration. As observed in this plot, there is a
consistent increase in average particle counts for the antibody spots with an increase
in E.coli concentration. However, the average count on the BSA control spots stays
relatively constant with an increase in E.coli concentration, confirming that we do
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Figure 2·9: Histogram count of antibody spots on 4 different IRIS
chips based on the number of captured bacteria particles on each an-
tibody spot. The bar plots with colors blue, yellow, green and purple
correspond respectively to E. coli sample concentrations of 3.2 × 10
CFU/ml to 3.2 × 104 CFU/ml, shown with C1 to C4. The color-coded
line plots show the Poisson distribution fits corresponding to each his-
togram count, confirming the independency of each binding event from
one another. (Zaraee et al., 2020a)
not observe nonspecific binding of E.coli bacteria to the BSA control spots.
As shown in Figure 2·10b, a desirable linear relationship was found in the log–log
plot of the average particle count per mm2 on antibody spots and the E. coli con-
centrations. The corresponding linear regression equations is y = 0.46 x + 0.25 with
a good correlation of R2 = 0.93. Next, based on the acquired linear regression line
and the sensor background signal we can calculate the LOD which has been also
explained in other studies (Little, 2015; Monroe et al., 2013; Long and Winefordner,
1983). The background signal is acquired from average particle count per mm2 plus
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(a) (b)
Figure 2·10: (a) Semi-log plot of the average particle counts per mm2
for antibody (blue squares) and BSA spots (orange circles) on the IRIS
chips based on the E. coli concentration in PBS buffer. The standard
deviation of the counts is shown as an error bar for each concentration.
The inset shows the zoomed-in section of the same plot for the blank
sample and the first two E. coli concentrations. (b) log–log plot of the
average particle counts per mm2 for antibody spots based on the E. coli
concentration in PBS buffer. The dashed black line shows the linear fit
to the data points, with a correlation of R2 = 0.93 to linear regression
equation of y = 0.46 x + 0.25. (Zaraee et al., 2020a)
3 times the standard deviation of the sensor response for the blank sample. This
background signal is then used to extrapolate a bacteria sample concentration using
the linear regression shown in the log–log plot of Figure 2·10b. Based on this formula,
we acquire an extrapolated LOD per mm2 of 2.2 CFU/ml.
The orange (and blue) dashed line in this plot indicates the linear fits for the first
three (and two) data points corresponding to the first three (and two) E. coli sample
concentrations. The corresponding linear regression equations is y = 0.67 x - 0.28 (y
= 0.92 x - 0.75) with a good correlation of R2 = 0.95. This confirms the great linear
response of our biosensor for the lower bacteria sample concentrations. As discussed
in the previous paragraph, following the established methods for LOD calculations
from the linear fitting to the acquired data points, we achieved a sensitivity of 2.2
CFU/ml. However, we believe a more realistic approach to LOD calculation is through
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the linear fittings to the lower sample concentrations where the biosensor response
is more linear. As seen from the equations of the orange and blue lines, the slope
of the linear fittings is getting closer and closer to 1, which is the perfectly linear
response, as we move toward lower sample concentrations. The extrapolated LOD
calculated from these two linear fittings, are 10.5 and 18.1 CFU/ml which is still
impressive compared to the existing technologies. The slope of 1 corresponds to the
dependency of the sensor sensitivity on the volume of the incubating sample on the
sensor surface, rather than the sheet dependency in case of fast flowing sample over
the sensor surface.
2.5.3 Effect of increasing the sensor area on the assay sensitivity
The ability to perform multiplexed and high-throughput measurement is an important
characteristic of a biosensor.To obtain a meaningful data that will result in detection
of a biological target, generally there should be a minimum of 3 replicates to calculate
an average and standard deviation of a measurement. There is a trade-off between
the number of measurements and the number of replicates of each measurement which
could be achieved in a biosensor. For example, a higher number of targets for mul-
tiplexed detection will result in less available replicates for each target measurement
because parts of the sensor area are allocated for the multiplexing capability.
Therefore,investigating the surface sensitivity dependency of our biosensor is a
valuable study for recognizing the required surface area for various experiments. In
order to investigate the effect of sensor area on the sensitivity of our biosensor, we
calculate the LOD per mm2 for different sensor sizes, as shown in Figure 2·11. Here,
the sensor size is defined as the surface area of the immobilized antibody spots on
the IRIS chip; therefore, each data point in this plot correspond to different sensor
sizes, considered as the combination of 1, 4, 9, ..., 50 antibody spots. Basically, the
average and standard deviation of the particle count for combination of n spots is
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Figure 2·11: LOD per mm2 based on different sensor sizes, shown
with black square data points. The red solid line shows the non-linear
fitting to the data points with the equation y = 23.32 x-0.59 + 1 and a
great correlation of R2 = 0.99. (Zaraee et al., 2020a)
calculated for the chip incubated in the blank sample. Theoretically, from the LOD
formula dependency on the standard deviation, we expect a decrease in the LOD per
mm2 by increasing the sensor size, with a rate of 1/
√
n where n is the sensor area.
As shown in figure 2·11, the experimental data points’ decrease rate shows a close
agreement to the expected theoretical value, confirmed by the great correlation of R2
= 0.99 to the nonlinear fitting function of y = 23.32 x0.59 + 1. So, by increasing the
available functionalized sensor surface, we could theoretically decrease our LOD even
more than reported values. In other words, because our biosensor has the capability of
detecting down to single bacteria level, the limiting factor for increasing its sensitivity
is improving the capture efficiency of target bacteria in a solution.
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2.5.4 Sensor specificity test
To evaluate the detection specificity of our biosensor, we performed the same exper-
imental condition as E.coli for other non-target bacteria. The spotted IRIS chips
with Anti-E. coli antibody were incubated with target bacteria E. coli and non-target
bacteria including S. aureus, K.pneumonia and P. aeruginosa at 104 CFU/ml.
Figure 2·12: Bar plot of average particle counts per antibody spot for
IRIS chips incubated in target bacteria E. coli and non-target bacteria
S. aureus, K.pneumonia and P. aeruginosa at 104 CFU/ml. The stan-
dard deviation of the particle counts is shown as the error bars for each
bacteria type. (Zaraee et al., 2020a)
Figure 2·12 shows the average particle count per antibody spot (for hundreds of
spots covering the biosensor surface) for different bacteria samples and the standard
deviation of the particle counts is shown as the error bars in the plot. It is important to
note that the error bar shown here is the deviation of the particle counts for a sensor
surface equal to the area of one antibody spot. Taking into account the Poisson
35
nature of our single bacteria counting signal which shows the bacteria capture in our
biosensor represents independent events, we expect the variance of a random discrete
number with an average value of N equal to the square root of N. As shown in Figure
2·12, Since the average count for E. coli is about 8, the variance is little under 3. This
shows that the confidence in detection using only one spot is sufficiently high at the
concentration used for the data in Figure 2·12.
The results show that our biosensor has a much higher affinity to E.coli and
negligible cross-reactivity to S. aureus, K.pneumonia and P. aeruginosa. Therefore,
our developed sensor platform provides a great specificity to the target bacteria,
confirming its application in multiplexed samples.
2.5.5 Tap water calibration curve
To obtain the calibration curve for unprocessed tap water sample,we analyzed the
images taken from the IRIS chips incubated in tap water spiked with E. coli samples
with concentrations ranging from 3.23 × 10 to 107 CFU/ml. The average particle
counts per mm2 for antibody and BSA spots as a function of E. coli concentration is
shown by the semi-log plot in Figure 2·13a, where the 0 concentration corresponds to
blank tap water incubation sample.
The antibody spots of the IRIS chips for tap water experiments have a diameter
of 210 µm, and therefore the surface area of around 29 antibody spots corresponds
to 1 mm2 of a functionalized IRIS chip. The same analysis procedure of the PBS
experiment is carried out here to obtain the tap water samples’calibration curve.
As indicated in Figure 2·13a plot, unlike the BSA control spots, the average counts
on the antibody spots show a clear increase by increasing the E. coli sample concen-
trations. Figure 2·13b depicts the log–log plot of the antibody spots’ average counts
as a function of E. coli sample concentration which show a good correlation of R2 =
0.89 to the linear regression line y = 0.34 x + 0.41.
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(a) (b)
Figure 2·13: (a) Semi-log plot of the average particle counts per mm2
for antibody (blue squares) and BSA spots (orange circles) on the IRIS
chips based on the E. coli concentration in spiked tap water samples.
The standard deviation of the counts is shown as an error bar for each
concentration. The inset shows the zoomed-in section of the same plot
for the blank sample and the first two E. coli concentrations. (b) log–log
plot of the average particle counts per mm2 for antibody spots based
on the E. coli concentration in spiked tap water samples. The dashed
black line shows the linear fit to the data points, with a correlation of
R2 = 0.89 to linear regression equation of y = 0.34 x + 0.41. (Zaraee
et al., 2020a)
The orange (and blue) dashed lines in this plot indicate the linear fits for the first
three (and two) data points corresponding to the first three (and two) E. coli sample
concentrations. The corresponding linear regression equations is y = 0.68 x - 0.45
(and y = x - 1.03) with a good correlation of R2 = 0.94. This confirms the great
linear response of our biosensor for the lower bacteria sample concentrations. It is
important to note that the slope of this linear fit is very similar to the slope of the
orange dashed line in Figure 2·10b which shows our biosensor’s consistent response
to the pure buffer sample and the complex tap water solution.
2.5.6 Discussion
Here, we successfully demonstrated the E. coli bacteria detection with an LOD as low
as 2.2 CFU/ml, by digital detection and counting of the captured E. coli particle on
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the sensor surface. Table 2.1 shows comparison of our work with the most common
optical biosensors in their key properties such as: detection sensitivity, detection
time, type of bioreceptor required, and sensor complexity (Ahmed et al., 2014; Yoo
and Lee, 2016). Here, we focus on the biosensors which provide whole-cell E. coli
bacteria detection capability, therefore requiring no sample pre-processing.
As indicated in table 2.1, fluorescence-based biosensors could offer high detection
sensitivity. However, the additional time and cost required for labeling the target
analyte with the fluorescent reagents, is a major drawback of these biosensors which
hinders their applicability for a rapid and cost-effective detection technique (Ahmed
et al., 2014). Recently, Müller et al. showed a smartphone-based fluorescence mi-
croscope which offers a cost-effectiveness and field-portable biosensor for bacteria
detection in complex samples (Müller et al., 2018). SPR-based biosensors are one of
the most common types of label-free optical biosensors. The early types of SPR-based
biosensors suffered from low sensitivity, especially for detection of whole bacteria, due
to similar refractive index of bacteria with the surrounding medium and small pene-
tration depth of the electromagnetic field into the bacteria. In recent years, various
strategies have been introduced to improve the sensitivity of SPR biosensors such as
long-range SPR and SERS as shown in table 2.1.
Also, it has been shown that an increased penetration depth of the evanescent field
for higher sensitivity is achieved in metal-clad waveguides (Skivesen et al., 2007), by
employing a metal layer in the substrate, and reverse symmetry waveguides (Horváth
et al., 2003), by making the substrate’s refractive index smaller than the refractive
index of the analyte medium. As a special case of these biosensors, optical leaky
waveguides have proven to offer better performance compared to SPR for detecting
larger targets such as bacteria which require a larger penetration depth of the evanes-
cent field to interact with the larger volume of the bound bacteria to the sensor
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surface (Hulme et al., 2011; Mukundan et al., 2009; Xiao et al., 2012). Zourob et al.
showed a detection limit of 8 × 104 spores/ml for Bacillus subtilis var. niger (BG)
bacteria with metal-clad leaky waveguide sensor (Zourob et al., 2005). However, SPR
biosensors in general are complex, expensive and large equipment and therefore not
suitable fora point of care diagnostic tool (Ahmed et al., 2014; Yoo and Lee, 2016).
To address these limitations, Tripathi et al. developed a more compact and cost-
effective SPR biosensor based on long-period fiber gratings. Nonetheless, it suffers
from low sensitivity as shown by its higher LOD compared to the other SPR biosen-
sors. Finally, the colorimetric biosensors offer a portable, cost-effective detection
technique which rely on color change of the reporting solution, detectable by naked
eye due to the bacteria presence. However, these biosensors have several disadvantages
including low sensitivity, limited multiplexing and quantification capability (Yoo and
Lee, 2016). Our biosensing platform offers an LOD of 2.2 CFU/ml with a 2-hour de-
tection time for rapid and highly sensitive and specific bacteria detection through an
interferometric substrate which can be functionalized with many capture probes for
a high-throughput and multiplexed detection. Although there are other techniques
described in table 2.1 which offer a more rapid detection time, they suffer from other
limitations such as low sensitivity, requiring sample processing or labeling, which are








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this chapter, we have presented a rapid, label-free and cost-effective optical biosen-
sor for detection of whole-cell E. coli. Enabled by our ability to count individual bac-
teria on a large sensor surface, we demonstrate an extrapolated LOD of 2.2 CFU/ml
from experimental data in buffer solution. Our approach relies on direct binding
of whole bacteria to the sensor surface through antibody-antigen interaction, which
is advantageous in terms of no sample pre-processing or modification requirement,
compared to the techniques detecting bacterial molecular components.
The simple, robust and rapid detection technique presented here, addresses the
aforementioned limitations of the traditional bacteria detection techniques. The sim-
ple design of our optical setup with off the shelf optical components ensures a cost-
effective instrument for bacteria detection without requiring specialized facilities or
highly trained users. The specificity of our biosensor is validated by comparing the
response to target bacteria E. coli and non-target bacteria S. aureus, K. pneumonia
and P. aeruginosa.
The biosensor’s performance in tap water also proves that its detection capability
is unaffected by the sample complexity. Furthermore, our sensor platform provides
high optical magnification imaging and thus validation of recorded detection events as
the target bacteria based on morphological characterization. Therefore, our sensitive
and label-free detection method offers new perspectives for direct bacterial detection
in real matrices and clinical samples.
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Chapter 3
SP-IRIS with DNA-Directed Antibody
Immobilization for enhanced detection of
whole cell E. coli: Real-time measurement
3.1 Motivation
As discussed in previous chapter, we developed an optical biosensor for label-free,
rapid and sensitive whole-cell bacteria detection requiring zero sample preparation
(Zaraee et al., 2020b). Although our developed biosensor offers unique advantages
with sensitivity levels which have not been reported so far for label-free bacteria
detection, its end-point measurement functionality creates certain limitations on using
it as a point of care (POC) diagnostic tool. In this modality, the sensor surface
imaging and bacteria detection is performed after the sensor incubation and washing
steps, which affects our detection time. In addition, these steps require the user to
directly operate the sensor incubation and washing which could increase the chance of
contamination and human error if not carefully handled. In this chapter, we improve
upon our previous study to address these limitations by developing a biosensor for
real-time in-liquid bacteria detection. This improved detection modality is achieved
by integrating our optical biosensor with a microfluidic flow cell which offers significant
advantages by enabling in-liquid real-time imaging of the sensor surface.
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3.2 Sensor surface capture efficiency enhancement
A biosensor’s performance in sensitive and rapid target detection is strongly depen-
dent on its ability to successfully capture the target analyte on the sensor surface
through its designed capture probes. Therefore, one of the most important aspects
in improving a biosensor’s sensitivity is optimizing the surface chemistry for capture
probe immobilization. As we work toward utilizing our developed biosensor for a POC
diagnostic platform, we should optimize the capture efficiency of antibody microarray
chips used in previous study described in chapter 2.
The ideal surface chemistry used to modify the substrate surface should meet the
following requirements: 1- high availability of functional groups for probe attach-
ment, 2- preventing non-specific binding to the surface and therefore providing low
background noise, 3- allowing the immobilized molecules to retain their conformation
and functionality after immobilization. There are three general categories of surface
chemistry used for antibody immobilization on glass surfaces: (i) physical adsorption,
(ii) covalent attachment, and (iii) affinity-based interactions (Sl et al., 2007). In the
next few paragraphs we provide a brief description of these immobilization techniques.
3.2.1 Physical adsorption
Physical adsorption is the simplest immobilization technique which is achieve through
hydrophobic or ionic interactions between the protein capture probes and the glass
surface. Despite its simplicity, this technique has disadvantages such as capture probe
loss during assay procedure which can decrease the assay sensitivity and reproducibil-
ity. In addition, this immobilization technique causes variability between spots on a
single slide and between microarrays on different slides (Sl et al., 2007).
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3.2.2 Covalent attachment
covalent attachment provides a more robust and permanent immobilization of the
antibodies on the surface which addresses the problem of probe loss during assay
procedure in physical adsorption. Robust covalent binding of the antibodies to the
surface could be achieved by introducing chemically functional groups such as hy-
droxyl, carboxyl, thiol, amine and many others to the sensor surface (Welch et al.,
2017). Although covalent attachment overcomes the issues of antibody loss, this
technique has other issues which need to be addressed.
One of these issues is caused due to availability of multiple binding sites in most
proteins, leading to attachment of the proteins to the sensor surface through multi-
ple sites which could affect antibody activity by masking the antigen binding sites
(Sun et al., 2013; Schwenk et al., 2007). Additionally, the random orientation of the
antibodies after immobilization using this technique, can results in loss of their bind-
ing site functionality due to steric hindrance by the surface and adjacent antibody
molecules (Peluso et al., 2003). Lastly, direct antibody immobilization on the sensor
surface poses challenges in terms of storage stability of the microarrays (Gerdtsson
et al., 2016).
3.2.3 Affinity-based attachment
To address the limitations of the protein microarrays, alternative methods for protein
immobilization have been explored. Affinity-based immobilization techniques utilize a
specific functional group on the antibody which results in controlled orientation of the
immobilized antibodies on the surface and therefore availability of its antigen binding
site for the assay procedure. The most commonly used affinity-based technique is
using a specific tag for the antibody which has high affinity to a pre-designed surface
functional group.
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DNA-directed immobilization (DDI) of antibodies, first introduced over 20 years
ago (Niemeyer et al., 1994), is one such technique which is based on selective bind-
ing of the proteins-DNA conjugates, to their complementary DNA capture probes
immobilized on the sensor surface. The key advantages of this technique have made
it a promising alternative to protein microarrays. Some of these advantages include:
1) Easy and repeatable DNA microarray fabrication, 2) Stability and robustness of
DNA chips, 3) Minimum chance of antibody denaturation after immobilizing by pro-
viding the antibodies a soft landing (Carvalho et al., 2018) , and 4) Enhanced antigen
capture efficiency through a more flexible link of the antibody to sensor surface, as
opposed to a shorter and more rigid attachment (Washburn et al., 2011).
3.3 DDI utilization in SP-IRIS for E. coli detection
The advantages of the DDI technique for antibody immobilization, motivated us to
utilize it in our study. Therefore, here we demonstrate the enhanced capability of
our biosensor in bacteria detection by employing DDI technique for capturing the
target analyte. Although, protein microarrays have proven to be powerful diagnostic
tools for various biological targets, the challenges associated with their fabrication
have limited their extensive capabilities. To address these challenges, we have utilized
IRIS chips functionalized with single-stranded DNA (ssDNA) which will be converted
to the desired Protein microarray using antibodies labeled with the complementary
DNA sequence to the surface probes.
We also demonstrate a homogenous bacteria capture assay where the bacteria
sample and the DNA-Ab conjugates are first mixed in solution phase, and then in-
cubate with the DNA coated IRIS chips. It has been previously shown that DDI
technique offers advantages in terms of antigen binding capacity (Seymour et al.,
2015; Washburn et al., 2011; Seymour et al., 2021), as well as spot homogeneity and
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assay reproducibility (Wacker et al., 2004; Wacker and Niemeyer, 2004), compared to
directly immobilized antibodies.
In addition, the binding specificity and diversity of DNA sequences, makes this
platform a perfect candidate for multiplexed target detection (Boozer et al., 2006).
Capture probes specific to various target analytes, tagged with different DNA se-
quences, could be easily directed and immobilized on predesigned spots on the chips
surface, by pattering it with their complementary DNA sequences. Moreover, DDI
technique offers an economic advantage compared to direct immobilization, by re-
quiring much less antibody for microarray fabrication.
3.4 Experimental protocol
3.4.1 Sensor surface functionalization
The first step for functionalizing the layered Si/SiO2 chip is the cleaning step including
sonicating in acetone, rinsing with methanol and DI water and finally drying under
nitrogen. The next step is the sensor surface activation by a treatment with oxygen
plasma which activates the silanol groups on the surface. Finally, the activated chips
are coated with MCP-4 copolymer from Lucidant Polymers (Sunnyvale, CA, USA)
which is a copoly- (DMA-NAS-MAPS) polymer described in detail elsewhere (Cretich
et al., 2004). The polymer coating on the chip surface provides functional groups for
immobilizing antibodies of interest as well as amine-modified DNA molecules. The
coating process is done by immersing the chips for 30 minutes in the polymeric solu-
tion, followed by rinsing with DI water and drying with nitrogen. The polymer-coated
chips are then cured at 80 ◦C for 15 minutes and kept in desiccator for microarray
printing.
47
3.4.2 Antibody-DNA conjugation process
5′-aminated ssDNA molecules were purchased from Integrated DNA Technologies
(IDT). As reported in a previous study (Brambilla et al., 2021), to perform the
antibody-DNA conjugation, antibodies were first modified with a bifunctional linker
bearing N-Oxysuccinimide Ester at one end and Dibenzocyclooctine (DBCO) at the
other end to allow their binding to azido modified oligonucleotides. Briefly, the
azido-modified oligonucleotide was added to DBCO-modified antibody and the strain-
promoted 1,3-Dipolar Cycloaddition of Cycloalkynes to azide reaction was carried out
overnight at 37 ◦C. The unreacted oligonucleotide was eliminated through centrifu-
gation over an Amicon Ultra 100K filter. After the final purification, 100 µL of
ssDNA-modified antibody at 1 mg/ml concentration was obtained.
Table 3.1 shows the DNA sequence (A) used for conjugation to the E. coli anti-
body, its complementary surface probe (A′), second DNA sequence used as negative
control (B′) during real-time bacteria detection assay, and the stabilizer DNA se-
quence (C) which partially binds to the surface probes for a more rigid structure.
The 20-bp DNA (A) linked to the antibody, has a 5-bp polyA sequence as a spacer,
and is partially complementary to the 40-bp DNA surface probe (A′). The com-
plementary regions between these two sequences are shown with bold font in Table
3.1.
In addition, we designed both DNA surface probes, (A′) and (B′), such that their
first 20 sequences are the same, hence simplifying our design parameters by using
one common stabilizer DNA (C) for both surface probes. The short stabilizer oligo is
complementary to the end of the surface capture probe closest to the sensor surface
shown by the underline in Table 3.1. The reason for using the stabilizer sequence is
achieving a higher affinity to the target bacteria by forming a double stranded DNA
(dsDNA) structure between the sensor surface and complementary region of the probe
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to the target DNA label.
This higher affinity is due to the lower flexibility of dsDNA compared to a ssDNA
and increasing the distance between the target complementary region of the surface
probe and the sensor surface by the rigid dsDNA structure (Sevenler, 2017). We used
OligoAnalyzer tool (Integrated DNA Technologies) for designing the DNA sequences
used in this study to make sure we don’t observe hairpin, self-dimer, and heterodimer
structures, and therefore optimize the hybridization efficiency and prevent cross hy-
bridization.
Table 3.1: DNA Sequences Used for Antibody Conjugation and Sur-
face Probes.
Sequence
A: 5′ AAAAAGCCTACGAATGAACAGACTG 3′
A′: 5′ ATATGTACCCACCGCTATTCCAGTCTGTTCATTCGTAGGC 3′
B′: 5′ ATATGTACCCACCGCTATTCTAGACTTCAGCGTGGTTGGA 3′
C: 5′ ATAGCGGTGGGTACAT 3′
3.4.3 Printing of biomolecules on sensor surface
Microarray printing on the polymer-coated chip surface is performed using a Scienion
sciFLEXARRAYER S3 (Berlin, Germany) piezoelectric arrayer. The antibody is
spotted at a concentration of 3 mg/ml (in PBS and 100 mM Trehalose), resulting in
antibody spots of ∼ 150 µm diameter. 5′-aminated ssDNA surface probes (A′ and
B′) were first mixed with the stabilizer DNA probes (C) each at a concentration of
25 µM in printing buffer (150 mM sodium phosphate, pH = 8.5, containing 0.01%
w/v sucrose monolaurate) and spotted, producing DNA spots of ∼ 100 µm diameter.
The spotted chips were kept in the spotter chamber overnight at 57% humidity to
allow time for the biomolecules to immobilize on the surface. After the biomolecule
printing, the chips are placed in a buffer of 50 mM ethanolamine and 100 mM tris-
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HCl (pH = 9) solution for one hour. This step is performed to prevent nonspecific
binding of the target cells to the available binding sites on the chip by blocking them
with the passivating agent (Ethanolamine). Figure 3·1 shows the image of the sensor
surface after microarray printing with the first three columns representing DNA A′,
E. coli antibody, and DNA B′ which are repeated throughout the whole chip.
Figure 3·1: Image of the sensor surface showing microarray spotting
schematics.
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3.4.4 Bacterial sample preparation
In order to prepare the required bacterial samples for the experiments in this study,
we first incubate the E. coli K-12 colonies, purchased from ATCC, with LB broth at
37 ◦C for 14 hours. Next, we spin down the culture at 13000 rpm for 10 minutes at
4 ◦C and then reconstitute it in sterile PBS. The concentration of the E. coli stock
is determined through measuring its absorbance at 600nm using a spectrometer (1
OD600 = 108 CFU/mL), shown schematically in figure 3·2.
We then prepare the bacteria sample concentration ranging from 107 CFU/ml
to 103 CFU/ml, by performing 10X serial dilutions of the original E. coli solution
stock, described in figure 3·2. Finally, Tween-20 at a final concentration of 0.1%
was added to each E. coli dilution sample, to prevent bacteria aggregate formation
and non-specific bacteria binding to sensor surface. It has been shown in previous
studies (Toutain-Kidd et al., 2009; Wu et al., 2013), that nonionic surfactants such
as Tween-20 could prevent bacteria biofilm formation at solid–liquid interface.
3.4.5 Fluorescence experiment for confirming DDI-based antibody im-
mobilization
As shown in figure 3·3, we performed a fluorescence experiment to confirm the suc-
cessful binding of the DNA-tagged antibody molecules to the DNA-coated IRIS chips.
First, three IRIS chips were pre-treated with oxygen plasma for 10 minutes. To coat
the chips, MCP-2 copolymer was dissolved in DI water to a final concentration of 2%
w/v and then diluted 1:1 with a solution of Ammonium Sulphate 1.6 M. To prepare
functionalized chips for fluorescence experiments, Surface probe A′ was dissolved at
10 M concentration in 150 mM sodium phosphate buffer, pH 8.5, containing 0.01%
w/v sucrose monolaurate and spotted on the chips using a noncontact microarray
spotter (sciFLEXARRAYER S12, Scienion, Berlin) equipped with an 80 m nozzle.
Four hundred pL drops of spotting solution were deposited at room temperature and
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Figure 3·2: Bacteria sample preparation and quantification schemat-
ics.
65% humidity. The spotted chips were kept overnight in the humid chamber and
finally treated with the blocking solution as previously described in section 3.4.3.
The chips were then incubated with 5 µg/mL solutions of E. coli ab-A conjugate
for 1 hr at room temperature, washed 10 minutes in PBS, rinsed with DI water
and dried under nitrogen stream. Next, we incubated the chips with a 10 µg/mL
solution of Cy3-labeled rabbit anti-mouse IgG in PBS for 1 hr at room temperature,
followed by a PBS wash for 10 minutes, DI water rinse and then nitrogen stream
drying. Finally, fluorescence images were acquired using ScanArray Lite confocal
laser scanner with 65% laser power and 55% PMT. Figure 3·3 shows the acquired
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Figure 3·3: Fluorescent detection of DNA-directed antibody immobi-
lized on DNA-coated IRIS chip.
fluorescent images from the sensor surface, confirming successful binding of the E.
coli ab-A conjugate to their complementary surface probes.
3.4.6 IRIS Optical Setup and data Analysis for optimizing DDI-based
antibody immobilization
We also confirmed and optimized binding of the DNA-tagged antibody to their com-
plementary DNA probes on the sensor surface using the interferometric reflectance
imaging sensor (IRIS). The IRIS system has been widely described in the literature
(Daaboul et al., 2011; Chiodi et al., 2020). Briefly, its working principle is based
on the interference properties of layered substrates. In our case, the substrate is a
silicon chip with a 110nm-thick SiO2 layer thermally grown on top. By illuminating
such a substrate from above with a multi-wavelength source, the system acts as a
common-path interferometer and a reflectance curve can be generated. Accumula-
tion of biomaterial on the surface results in a shift of such curve, and constructive
interference can be achieved at a specific wavelength. Both the wavelength and the
thickness of the oxide layer are engineered in order to maximize the change in signal
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due to biomass accumulation.
In order to directly convert the acquired signal to mass per unit area, the re-
flectance curve should theoretically be measured at each time point to build a direct
correlation. However, this step can be avoided thanks to the use of a look-up ta-
ble, generated by acquiring a four-color image at the start of the experiment . This
allows us to acquire the real-time binding signal at a single wavelength, improving
the computational speed and time sensitivity. In this case, the LED used for the
measurements has a wavelength spectrum centered around 456nm (blue). Images of
the sensor surface were acquired in real-time with Micro-Manager software and were
then analyzed by means of custom-made plugins in ImageJ. The signal conversion to
mass per unit area through the look-up table was performed in MATLAB.
3.4.7 Optical biosensor setup for real-time bacteria detection
The real-time bacteria detection experiments were performed in-solution with SP-
IRIS. Figure 3·4a shows the SP-IRIS optical setup where the sensor surface is illumi-
nated with a single wavelength LED (525 nm) through köhler illumination. As shown
schematically in figure 3·4a, the illumination light is propagated by a 4f system to
the beam splitter and the back focal plane of the objective. The light reflected from
the sensor surface is collected by the objective and guided through the tube lens to
the camera sensor.
Generally, when one designs an optical setup for single particle imaging, the re-
quired optical resolution is one of the most critical design aspects to ensure successful
target detection and characterization. Additionally, the provided FOV in the optical
setup for the real-time experiment is another important criterion to consider, which
ensures a high throughput target detection. In our previous study on end-point bacte-
ria detection (Zaraee et al., 2020b) , we utilized a dual modality imaging setup which
gave us the opportunity to take advantage of both these characteristics depending on
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the type of measurement by switching between the imaging modalities.
Here, we have improved our optical setup to provide a large FOV and high optical
resolution simultaneously, therefore enabling us to perform real-time high-throughput
bacteria detection and shape characterization with single-cell level resolution. This
improved design was achieved through optimized selection of the objective lens (with
low magnification and high numerical aperture) and the camera sensor (with large
sensor area and smaller pixel size). The objective used in this study has a 10X
magnification and 0.45 Numerical Aperture (NA) which is paired with a new camera
sensor with 2.74 µm pixel size and 5320 × 4600 resolution. The provided pixel size
ensures a diffraction-limited system with theoretical optical resolution of 580 nm. In
addition, the combination of the large camera sensor area with the 10X magnification
objective provides us with a FOV of ∼ 1.5 mm × 1.3 mm for a high-throughput
bacteria detection.
3.4.8 Microfluidic chamber design
To perform real-time, in-liquid imaging of the sensor surface, our designed optical
setup is integrated with a microfluidic chamber, which consists of the Si/SiO2 sensor
surface, double-side pressure sensitive adhesives (PSA) spacer layer, and an anti-
reflection (AR) coated cover glass to close the chamber and image through, as de-
scribed in the inset of figure 3·4a. The cover glass has AR coating on one side to
reduce the effect of reflections from the air/glass interface, therefore enhancing the
quality of the acquired images significantly.
The dimensions of the fluid channel in the spacer layer are 6 × 8 × 0.13 mm which
results in a fluid chamber volume of ∼ 10 µl (with considering the chamber corner
spaces). The inlet and outlet through holes on the sensor surface allow the bacteria
sample solution to flow over the functionalized chip surface. As described schemati-
cally in figure 3·4b, this assembled cartridge unit is then placed in a designed fixture
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(a) (b)
Figure 3·4: (a) Optical biosensor setup design for real-time bacteria
detection utilizing a köhler illumination path and a 10X/o.45NA. The
inset shows the fluid chamber assembly consisting of the IRIS chip
substrate, double-side pressure sensitive adhesives (PSA) spacer layer,
and AR coated cover glass. (b) schematic of the sample devilry system
to the microfluidic chamber, consisting of Hamilton PSD/6 Precision
Syringe Pump and connecting tubing.
with pressure seal to prevent leakage and connect to the syringe pump (Hamilton
PSD/6 Precision Syringe Pump purchased from Hamilton company) through tubing.
3.4.9 Real-time particle detection and tracking analysis
Throughout the whole assay procedure, we perform real-time imaging of the flow
chamber with 10 second time interval using Micro-Manager software. The acquired
image stacks are then analyzed with a custom-developed particle detection MATLAB
algorithm which we have built based on the Image Processing algorithm reported
here (Image Analyst, 2021). Once the particle detection analysis is performed for all
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the time frames in the image stack, the particle matching, and registered counting is
carried out.
The basis of the particle tracking code, previously developed in our group, is
described in detail elsewhere (Sevenler et al., 2019). Briefly, the pixel position of the
detected particles in each time frame is saved and compared with the next frames
to identify the bound particles on the sensor surface, for matching pixel positions of
the particles in consecutive time frames. The false positives (such as the case when
a target particle is only passing by in the flow chamber and is not captured on the
sensor surface), are removed from the final count by deleting the particles that are
only present in a single frame.
In addition, the false negatives (such as the case when a bound particle is not
visible and therefore not detected in a few frames, due to misaligned focus or wiggling
in place after a weak initial bound to sensor surface) are accounted for by repairing
the gaps in between the frames, in which we observe and detect the target particles
at the same pixel position.
3.4.10 Bacteria capture on sensor surface assay procedures
Figure 3·5 demonstrates the three different approaches utilized in this study for cap-
turing the target bacteria on the sensor surface. The first approach (shown in inset
a) is direct antibody immobilization on the sensor surface to capture the target bac-
teria. The heterogeneous and homogeneous DNA-directed bacteria capture assays
are shown schematically in insets b and c, respectively. The heterogeneous bacteria
detection experiments consist of two steps: First, the DNA spotted chips were incu-
bated with E. coli ab-A conjugate (5 µg/ml concentration) at static condition for 1
hour at room temperature, followed by a 10-minute PBS washing step and rinsing
with DI water.
In addition, we investigated the effect of kinetic flow, as opposed to the static
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incubation, for optimized binding of the E. coli ab-A conjugate to the complementary
DNA surface probes. Next, the bacteria binding experiments were performed by
flowing the bacteria sample solution at concentrations ranging from 103 – 107 CFU/ml
over the sensor surface, while capturing real-time images of the flow chamber.
The homogeneous experiment procedure eliminates the additional step of chip
incubation with the E. coli ab-A conjugate, required for antibody immobilization.
Instead, the bacteria sample is first mixed with the E. coli ab-A conjugate in solution
and the resulting solution is then introduced to the fluid chamber.
Figure 3·5: Schematic of three different procedures for bacteria cap-
ture assay on functionalized IRIS chips. (a) bacteria capture with direct
antibody immobilization. (b) heterogeneous DDI-based bacteria cap-
ture, consisting of two sensor surface incubation steps: DNA-tagged
antibody sample and target bacteria sample incubation. (c) homoge-
neous DDI-based bacteria capture, consisting of DNA-coated IRIS chip
incubation with the mixture of bacteria and DNA-tagged antibody sam-
ples, mixed previously.
All real-time experiments were started with filling the flow chamber with PBS to
acquire pre-incubation images of the sensor surface and prevent false positive counts
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from the already existing particles on the sensor surface. Next, the bacteria detec-
tion experiments were performed with a “stop-flow” mechanism, where the pump is
stopped for a while and then restarted again for a short time to make sure that the
bacteria solution in the flow chamber is not depleted. It has been shown in previous
studies that the “stop-flow” mechanism allows enough time for the bacteria to find
the sensor surface and bind to the target spots (Chamberlain, 2013). Unless stated
otherwise, all real-time bacteria capture experiments in this study were performed for
2 hours, including three incubation periods of 40minutes, with a duration of 10s flow
in between them to replace the fluid chamber with fresh bacteria sample.
After the E. coli sample flow, a washing step is performed by flowing PBS at 50
µl/mn speed over the sensor surface for 10 minutes. In addition to obtaining real-
time images of the sensor surface during assay procedure, its post-incubation images
were also acquired after the washing step. Finally, the acquired images were analyzed
with the particle detection and tracking algorithm for each spot, to get the average
number of target particles captured on the sensor surface.
3.5 Results and discussion
3.5.1 Comparison of static and kinetic incubation for DNA-ab conjugate
immobilization on sensor surface
Hybridization of DNA-modified antibodies to immobilized complementary sequences
is typically performed in static conditions, by depositing a droplet of the antibody
solution on top of the microarray-printed surface and waiting for the reaction to reach
equilibrium, which generally takes multiple hours (Niemeyer et al., 1999; Brambilla
et al., 2021). Here, we have verified the impact of dynamic flow conditions on the
hybridization efficiency of the chosen DNA-conjugated antibodies. For these experi-
ments, the functionalized IRIS chip was primed with PBS for 10 minutes prior to the
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injection of the sample. A solution of the E. coli ab-A conjugate at a concentration of
4 µg/mL was then introduced in the measurement chamber. The sample was left to
incubate in the chamber without any flow for 20 minutes, simulating static incubation
conditions.
Figure 3·6: Static VS kinetic incubation for the E. coli ab-A conjugate
capture on functionalized sensor surface.
As indicated in figure 3·6, during the static incubation period the DNA-conjugated
molecules started to hybridize, at a steady rate. Then, we increased the flow to 200
µL/min, allowing the sample to recirculate in the system for another twenty minutes.
Finally, the chamber was washed with 1X PBS for another 10 minutes.
As it can be clearly observed in the blue curve in figure 3·6, dynamic incubation
of the antibodies increases the hybridization rate dramatically, thus reducing the
amount of time needed in order to reach equilibrium. This experiment demonstrates
the high hybridization efficiency of the chosen DNA-conjugated antibodies, while also
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showing the strong impact of kinetic incubation conditions on its immobilization.
The two other curves in figure 3·6 (orange and red colors) show the trend of the
negative control (BSA) spots and the standard antibody spots. No binding on those
probes is measured, as expected. The observed shifting trend is most probably related
to the change in flow conditions of the chamber, and it can be considered insignificant.
The inset at the bottom of the plot shows acquired differential images of the
functionalized sensor surface at the start of the experiment, after the static and after
the kinetic flow of the DNA-conjugated antibodies, corresponding to the frame colors
of red, green, and blue. Each column of the spots in these images correspond to:
the DNA probes (A′) which are complementary to the DNA tags attached to the
antibodies, directly immobilized antibodies, and non-complementary DNA probes
(B′), as shown in the sensor surface image on the left. As expected from our biomass
accumulation plot, we observe a strong signal on the DNA (A′) spots after the kinetic
incubation, compared to its relatively weak signal after the static incubation.
3.5.2 Heterogeneous DDI-based bacteria capture comparison for static
and kinetic incubation of DNA-ab conjugate
In order to perform the heterogeneous bacteria detection experiments, we first pre-
pared two sets of IRIS chips functionalized with DNA-conjugated antibodies through
both kinetic and static incubation of sensor surface with the E. coli ab-A conjugate
sample. As observed in previous section, the kinetic incubation of the DNA-coated
IRIS chip with the E. coli ab-A conjugate increased their binding rate to sensor surface
dramatically compared to static incubation.
Next, we conducted the real-time bacteria capture experiments by incubating
these two sets of IRIS chips with the bacteria sample at 106 CFU/ml concentration,
while acquiring images of the flow chamber. These images were then analyzed with
our particle detection and tracking algorithm to obtain the final real-time binding
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plots.
Figure 3·7: Static VS kinetic incubation for the E. coli ab-A conjugate
capture on functionalized sensor surface. the blue and red panels on
both sides of the plot, show images of DNA spots before and after
bacteria sample flow for the kinetic and static E. coli ab-A conjugate
incubation conditions, respectively. The dashed circles indicate the
captured E. coli cells on the DNA spots after the sample flow.
Figure 3·7 shows the average count of captured bacteria per mm2 of functionalized
sensor surface during the course of the 2hr experiment, with stop-flow mechanism.
The blue and red plots correspond to IRIS chips prepared through kinetic and static
incubation of the E. coli ab-A conjugate sample, respectively. As expected, for the
same bacteria sample concentration we observed a much higher bacteria capture effi-
ciency on the blue plot, confirming higher rate for DDI-based antibody immobilization
on the sensor surface through kinetic incubation. The left blue and red panels of fig-
ure 3·7 show a zoomed-in image of DNA spots at t0 (before the bacteria sample flow)
from IRIS chips in kinetic and static incubation experiments, respectively. Next,
their corresponding image at tend (after the bacteria sample flow) is shown at the
right blue and red panels, confirming higher bacteria capture efficiency (shown with
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dashed black circles) for the kinetic incubation condition of the E. coli ab-A conjugate
for the same bacteria sample concentration.
3.5.3 Homogeneous DDI-based real-Time bacteria capture and detection
Despite the improvement of our biosensor in enhanced bacteria capture capability
by utilizing DDI technique, one limitation of the heterogeneous DDI-based detection
assay is the additional incubation and washing steps required for antibodyDNA con-
jugate immobilization on the sensor surface, before performing the target detection
experiment.
To address this limitation, we explored the homogeneous DDI-based detection
technique, where the E. coli ab-A conjugate (at a final concentration of 0.25 µg/ml)
is first mixed with 1ml of the bacteria sample in solution, before the incubation of
the chip surface. During the chip incubation with the resulting solution, images of
the sensor surface with 10s interval times were acquired. The particle detection and
tracking algorithm was then utilized for analysis of the acquired images, resulting
in the binding plots of the average number of captured bacteria per mm2 of the
functionalized sensor surface (through DDI) during assay procedure, shown in figure
3·8. These experiments were performed for bacteria concentrations ranging from 103
- 107 CFU/ml, confirming increased bacteria binding as the sample concentration
increases. We also performed the real-time homogeneous experiments for a blank
sample, which is 1ml of PBS buffer mixed with the antibody - DNA conjugates.
In addition, to demonstrate our biosensor’s great capture efficiency especially at
low sample concentrations, we performed the same analysis results as figure 3·8, but
focusing on the total number captured cells in our FOV during the real-time bacteria
detection experiments, shown in figure 3·9. As shown in the legend, this analysis is
shown for blank sample, and bacteria concentration of 103 and 104 CFU/ml which
corresponds to having an estimated number of 3.6 and 36 cells available in the FOV
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Figure 3·8: Real-time DDI-based homogeneous bacteria detection.
Binding plot of the average number of captured bacteria per mm2 of
the functionalized sensor surface as a function of assay time for bacteria
sample concentration range of 103 - 107 CFU/ml.
for capture on the sensor surface. The total number of captured cells in the FOV of
our sensor surface at the end of the real-time bacteria detection experiments, are 3
and 16 cells which correspond to capture efficiency of % 83 and % 44 for these sample
concentrations.
To estimate the total number of available cells in the FOV area, first based on
the sample concentration (for example: 104 CFU/ml) and the total fluid chamber
volume during the experiment (30 µL), we can calculate the number of available cells
in the chamber (104 (CFU/ml) ×30(µL) = 300 cells). Each chamber volume is 10 µL
and since we have three stop-flow steps during the 2-hour real-time experiment, there
are three chamber volumes exposed to the sensor surface throughout the experiment
which results in the total sample volume of 30 µL. Next, depending on the percentage
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of the microarray-printed chip surface shown in the FOV region (here % 12), the total
number of available target cells in the FOV is estimated (% 12 ×300cells = 36cells).
Figure 3·9: Real-time DDI-based homogeneous bacteria detection.
Binding plot of the total number of captured bacteria in the FOV area
of the functionalized sensor surface as a function of assay time for blank
sample and bacteria sample concentrations of 103 and 104 CFU/ml.
Figure 3·10 shows images of DNA spots from IRIS chips in the homogeneous DDI-
based bacteria detection experiments, at pre and post bacteria sample flow times (t0
and tend). The black dashed circles indicate the bound E. coli cells to the comple-
mentary DNA surface probes. The frame color for each DNA spot corresponds to the
incubating bacteria sample concentrations of 103 - 107 CFU/ml, confirming increase
in the number of captured bacteria cells on the DNA spots by increasing the bacteria
sample concentration.
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Figure 3·10: DNA spots from IRIS chips in the homogeneous DDI-
based bacteria detection experiments, at pre and post bacteria sample
flow times (t0 and tend).The frame colors correspond to the concen-
tration of the bacteria sample concentration ranging from 103 - 107
CFU/ml.
As described in previous section, in addition to the A′ DNA surface probes (for
immobilizing antibodyDNA conjugate), we also incorporated directly immobilized E.
coli ab and B′ DNA spots (as negative control) in the printed microarray on our sensor
surface. Therefore, to investigate the effect of DDI-based antibody immobilization on
enhanced bacteria capture efficiency of our biosensor, we also analyzed the captured
particle counts on the direct antibody spots on the sensor surface. Moreover, we
demonstrated our biosensor’s performance in specific detection of the target analyte
by studying the particle counts on the control B′ DNA spots.
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Figure 3·11: Average bacteria count per mm2 of the functionalized
sensor surface for three spotting conditions in our microarray: target
complementary DNA probe A′, directly immobilized E. coli ab, and
negative control B′ DNA spots, at bacteria sample concentration of 105
CFU/ml.
Figure 3·11 shows the real-time average bacteria count per mm2 of the func-
tionalized sensor surface for these three spots in our microarray, at bacteria sample
concentration of 105 CFU/ml. As observed in this plot, at the end of the experiment
we have more than 4 times bacteria capture count on the A′ DNA spots compared to
the direct Ab spots. Also, during the course of the experiment we observe increased
bacteria count on the A′ DNA spots compared to the relatively constant count on
the B′ DNA spot, confirming our biosensor’s capability for specific target bacteria
detection.
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3.5.4 Bacteria capture efficiency comparison for directly immobilized and
DNA-directed antibodies
Next, we confirmed enhanced capture efficiency of our biosensor through DDI com-
pared to direct Ab spots, for the bacteria full concentration range (103 - 107 CFU/ml).
Figure 3·12: Comparing bacteria capture efficiencies of directly im-
mobilized and DNA spots. The plot indicates the average bacteria
count/mm2 of the functionalized sensor surface with the DNA spots
and the directly immobilized antibody spots, shown with blue and red
diamonds, respectively, as a function of the bacteria sample concentra-
tion
Figure 3·12 shows the average bacteria count on the DNA spots and the directly
immobilized antibody spots at the end of the real-time experiment, as a function of
the bacteria sample concentration flowing over each IRIS chip. As observed from
these data points, at the lowest bacteria concentration (103 CFU/ml), no signal is
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observed on the directly immobilized antibody spots compared to the detected signal
of 21.2 on the DNA spots.
The data points (black squares) in Figure 3·13 show the ratio of the detected
bacteria counts on the DNA spots to the counts on the directly immobilized antibody
spots as a function of the bacteria sample concentrations. As shown from the non-
linear fitting to these data points, we observe that our biosensor’s capture efficiency
enhancement through DDI (compared to direct antibody spots) is much higher for
the lower bacteria sample concentrations. Considering for example the lowest and
highest bacteria sample concentration, the ratio of the average signal on DNA to the
direct ab spots changes from ∞ to 3.6 (ratio of 21.2/0 VS 725.7/200 for the lowest
and highest sample concentration, respectively).
The reason for this trend is that at lower sample concentrations, we have fewer
bacteria in the fluid chamber and making it more critical to have more available
binding sites on the sensor surface to capture the available targets. As discussed
earlier, the Antibodies immobilized through DNA linkers have higher flexibility and
more exposed binding sites compared to the directly immobilized antibodies, therefore
they have a higher chance of capturing the available E. coli cells in the chamber.
The enhanced capture efficiency achieved through DDI improves the dynamic
range of our biosensor by 100 fold compared to the direct ab immobilization, by
enabling bacteria detection for the sample concentrations as low as 103 CFU/ml (In
contrast to the 105 CFU/ml for the direct ab spots to get detectable signal). Dynamic
range is defined as the ratio of the highest concentration to the lowest concentration
of the target sample that can be detected.
3.5.5 End-point analysis for homogenous DDI-based bacteria detection
To determine the LOD of our biosensor in homogeneous DDI-based bacteria detection,
we performed an end-point measurement analysis of the sensor surface after the 2hr
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Figure 3·13: Comparing bacteria capture efficiencies of directly immo-
bilized and DNA-Tethered antibodies. The plot indicates the average
bacteria count/mm2 of the functionalized sensor surface with the DNA-
directed antibody spots as a function of average bacteria count for the
directly immobilized antibody spots
real-time experiments. For all sample concentrations, we utilized particle detection
algorithm on the images of the sensor surface acquired after the final PBS washing
step. Each data point in the semi-log plot of figure 3·14a shows the average bacteria
count per mm2 for the DNA-directed antibody spots as a function of E. coli sample
concentration, and the error bars correspond to the standard deviation of the particle
count on these spots.
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(a) (b)
Figure 3·14: End-point bacteria detection analysis and calibration
curve. (a) Semi-log plot of the average particle counts per mm2 for
DNA-directed antibody spots based on the E. coli solution concentra-
tion. The standard deviation of the counts is shown as an error bar
for each concentration. (b) log-log plot of the average particle counts
per mm2 based on the E. coli solution concentration. The dashed black
line shows the linear fit to the data points, with a good correlation of
R2 = 0.86 to the linear regression equation of y = 0.383 x + 0.43.
We observe a consistent increase in the average particle count with an increase
in the E. coli sample concentration. In order to obtain the calibration curve in our
experiment for quantitative analysis of unknown sample concentrations, we look at
the log-log plot of the average particle count per mm2 based on the E. coli sample
concentrations. As observed in figure 3·14b, a desirable linear relationship was found
to these data points. The corresponding linear regression equations is y = 0.383 x +
0.43 with a good correlation of R2 = 0.86. Using the slope of the regression line and
the sensor response to the blank sample, we calculate the LOD per mm2 (based on
the formula of “Average count + 3*Standard Deviation of counts for blank sample”)
to be 74.13 CFU/mL.
The orange dashed line in this plot indicates the linear fit for the first three data
points corresponding to the first three E. coli sample concentrations. The correspond-
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ing linear regression equations is y = 0.667 x - 0.655 with a good correlation of R2
= 0.99. This confirms the perfectly linear response of our biosensor for the lower
bacteria sample concentrations.
3.5.6 Bacteria capture efficiency comparison throughout the sensor sur-
face
As discussed earlier, we have optimized our optical setup by choosing the correct
combination of the camera sensor and the imaging objective to achieve the largest
FOV possible with single-cell level optical resolution. Our current FOV covers an area
of ∼ 1.5 mm × 1.3 mm on the sensor surface, which enables us to simultaneously
analyze 60 spots in our microarray. However, our microarray is extended beyond this
FOV, covering the whole central active region of the sensor surface.
In order to investigate the consistency of our sensor surface in bacteria capture
efficiency, we acquired images of the whole microarray area both before and after
the bacteria sample flow experiments. The pre-images of the sensor surface are used
to prevent false positive counts by eliminating the already existing particles on the
spots before bacteria sample flow. Figure 3·15 shows the average bacteria count per
DNA-directed ab spot as a function of the E. coli sample concentration in logarithmic
scale. The red and blue squares correspond to the average particle count for one FOV
and the entire microarray area, respectively, confirming consistent capture efficiency
through the entire sensor surface.
3.5.7 antibody usage comparison for DNA-directed and direct immobi-
lization assays
In each spotting run, 20 µL of a 3 mg/mL (60 µg) antibody solution is used and the
nozzle withdraws 5 µL of the antibody solution for spotting the chip with one drop
volume of approximately 120 pL. Assuming 1 drop is used for each spot, 41660 spots
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Figure 3·15: Bacteria capture efficiency comparison throughout the
sensor surface. The red and blue squares correspond to the average
particle count per DNA-directed ab spot, for one FOV and the entire
microarray area, respectively.
can be generated from the 5 µL antibody solution. The assembled IRIS chip with the
microfluidic flow chamber, provides an active area of 6 × 8 mm in the flow channel
available for microarray spotting with 520 spots. Therefore, with 60 µg of antibody
solution we can prepare around 80 functionalized chips.
For heterogeneous DDI-based experiments, with the kinetic flow condition (for
optimized antibody immobilization) we used 2 µg antibody (500 µL of 4 µg/mL Ab-
DNA conjugate) which circulates in the flow channel and tubing for generating an
antibody array on 3 DNA-coated IRIS chips. Therefore, it is possible to run 90 tests
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with 60 µg of antibody by using 2 µg of the conjugate for 3 tests.
In the homogeneous DNA-directed assay, we use 0.25 µg antibody (5 µL of 50
µg/mL Ab-DNA conjugate) for creating Ab microarray on 2 DNA-coated IRIS chips,
corresponding to 248 functionalized chips with 60 µg of antibody. Therefore, with
the same amount of antibody we can perform three times as many tests using the
homogeneous DDI technique compared to the direct Ab immobilization assay.
3.6 Summary
In this chapter, we have addressed the shortcomings of our developed optical biosensor
in end-point measurement modality which was presented in the previous chapter.
These limitations include direct user handling requirement for the sensor incubation
and washing steps and the longer detection time which stems from the end-point
detection modality of this biosensor. Here, we have utilized a microfluidic channel in
our optical biosensor enabling real-time bacteria detection in liquid as the bacteria
binding event occurs on the sensor surface, hence reducing the detection time and
eliminating the requirement for direct user handling of the sensor. Also, real-time
detection of the target binding could increase the sensitivity compared to the end-
point detection modality, especially in the cases where the interaction between the
target and the sensor surface is weak.
In addition, here we improved the applied surface chemistry technique for cap-
ture probe immobilization on sensor surface by utilizing DDI-based instead of direct
ab immobilization. The results we presented here show enhanced bacteria capture
and detection through both heterogeneous and homogeneous DDI-based compared to
direct ab immobilization, for bacteria concentrations of 103 - 107 CFU/ml.
We also demonstrated that the enhanced capture efficiency achieved in this study,
increased the detection dynamic range of our biosensor by 100 fold compared to
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direct ab immobilization technique. Therefore, the added advantages of our newly
developed biosensor such as integration of a disposable microfluidic flow cell and real-
time particle detection and tracking, makes it a perfect candidate for a sensitive,




Susceptibility Testing (AST) assay based
on monitoring individual bacterial
pathogens
4.1 Motivation
Antibiotics are a cornerstone of modern healthcare, saving millions of lives from their
discovery, as one of our most powerful tools for fighting infections. However, despite
their significant advantages, we now live at an era facing the growing global crisis of
antibiotic resistance as a result of their misuse and overuse over the years (WHO,
2020). Antibiotic resistance occurs when bacteria find new defense strategies called
“resistance mechanisms” against the antibiotic which was originally designed to kill
them. These defense strategies develop over time, eventually leading to formation of
antibiotic resistant infections.
Alarmingly, Antibiotic-resistant bacteria have the ability to transfer their resis-
tance genes to other bacteria that have not even been exposed to that antibiotic
(Luepke et al., 2017). In a recent report from CDC, it was estimated that in the
united states alone antibiotic-resistant infections account for more than 2.8 million
illnesses each year leading to over 35,000 fatalities. Additionally, antibiotic resistant
infections impose serious financial burdens on the global healthcare system, with more
than $100 trillion projected to be lost by 2050 as a result of this crisis (Centers for
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Disease Control and Prevention (U.S.), 2019).
When a patient with bacterial infection is hospitalized, in order to detect these
resistant bacteria, Antibiotic Susceptibility Testing (AST) is performed in clinics.
Current gold standard clinical techniques for AST are time-consuming culture-based
methods which take at least two days to generate the final outcome. The basis of
this method involves incubating the patient sample containing the infectious agents
with an antibiotic to determine the Minimum Inhibitory Concentration (MIC) which
stops the bacteria growth (Syal et al., 2017; Balouiri et al., 2016). MIC is defined
as the lowest required concentration of an antibiotic which prevents the growth of a
specific bacteria.
Currently, disk diffusion assay is the most practiced test in clinics which deter-
mines the MIC level of an antibiotic by 1- inoculation of bacteria cells (present in
patient sample) onto the surface of a culture plate. 2- placing sterile antibiotic paper
disks on the plate surface. 3- plate incubation (24-48 hr) and determination of MIC
by measuring the diameter of inhibition zone around each disk.
This delay prolongs the time to diagnosis of resistant bacteria and decisions for
appropriate and effective antibiotic therapy. At this point, doctors have to decide
whether they will wait for the final AST result for administration of the appropri-
ate therapeutics which leads to longer stay of patients in the hospital, poor clinical
outcomes and increased patient mortality as a result of sepsis development.
In most cases, instead of waiting for the AST outcome, patients are prescribed a
board-spectrum antibiotic which will in turn promote antibiotic resistance in time by
unnecessary increased community exposure to antibiotics. By the time the culture-
based AST outcome is reported, either the patient has already responded to the
prescribed broad-spectrum antibiotic which makes the test results irrelevant, or the
infection has been spreading due to delay in diagnosis.
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Therefore, there is a pressing need for rapid AST techniques which can identify the
pathogens responsible for an infection, as well as determine the most effective therapy,
fast enough for timely and appropriate treatment decision. Although performing AST
analysis was a stretch goal of this study, our promising initial results show significant
potential for our biosensor as a rapid AST analysis tool. Here, we will establish the
use of our developed optical biosensor, described in previous chapters, as a rapid,
low-cost, and quantitative diagnostic tool for assessing antibiotic susceptibility.
4.2 Experimental protocol
4.2.1 Bacteria and antibiotic sample preparation
E. coli K-12 colonies was purchased from ATCC, Gentamicin was purchased from
Milliporesigma as 10 mg/ml stock in DI water, Amipcillin was purchased from Milli-
poresigma as 100 mg/ml stock in PBS. As described schematically in figure 4·1, the
cultured E. coli in LB broth at 37 ◦C, was spun down at 13000 rpm for 10 minutes at
4 ◦C and then reconstitute in sterile PBS. We then performed serial dilution in borth
to get diluted E. coli sample in nutrient rich broth (9:1 broth:PBS buffer).
In order to investigate the bacteria growth rate changes under various antibiotic
challenge conditions, we diluted the gentamicin and ampicillin stock in PBS. Ampi-
cillin was added to the prepared bacteria sample at final concentrations of 5 and 500
µg/ml and gentamicin was added to the prepared bacteria sample at final concentra-
tions of 1 and 100 µg/ml. Table 4.1 shows the MIC levels of ampicillin and gentamicin
for E. coli bacteria.
Table 4.1: antibiotic MIC levels for E. coli
Bacteria Antibiotic MIC (µg/ml)
E. coli Ampicillin 2-8
E. coli Gentamicin 0.25-1
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Figure 4·1: Bacteria sample preparation from the E. coli stock in
broth by serial dilutions in broth. The various antibiotic challenges
were introduced to the prepared bacteria sample, by adding ampicillin
and gentamicin at different concentrations.
4.2.2 The optical setup requirement and modification for AST analysis
As demonstrated in previous chapter, the integration of our developed optical biosen-
sor with microfluidic channel, enabled us to perform in-liquid imaging of our sensor
surface in real-time, therefore detecting every bacteria binding event to our sensor
surface. In addition, the modified design of the optical system with optimized combi-
nation of the camera sensor and the imaging objective, enabled us to achieve single-
cell level optical resolution in a large FOV (∼ 1.5 mm × 1.3 mm), which is a critical
advantage for utilizing our biosensor for performing image-based AST analysis.
Here, we propose image-based AST analysis as an application of our biosensor by
estimating the bacteria growth rate changes in various introduced antibiotic concen-
trations into the fluid chamber. The bacteria growth rate is estimated by monitoring
the changes in the captured bacteria cell surface area.
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In order to provide the optimal growth condition for the bacteria, we applied
design modifications to the fixture and the chip holder to utilize the heating element
(HT15W, purchased from Thorlabs) for keeping the fluid chamber temperature at




Figure 4·2: (a) 3d view of the fixture design and the chip holder.
(b) (left panel) zoomed-in 3d view of the chip holder with the O-rings
and the fittings connecting to the tubing for sample flow, (right panel)
cross sectional schematic of the chip holder (with the assembled flow
chamber on top) showing the modification to the design to hold the
heating element, shown in the inset.
Figure 4·2a shows 3d schematic of the fixture design and the chip holder with a
planar position for easier cartridge placement. Figure 4·2b shows zoomed-in view of
the chip holder with the O-rings and the fittings for the tubing connections. The
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cross-sectional schematic of the chip holder block describes the cartridge placement
on the holder and the added modification for holding the heating element inside the
block.
4.2.3 Heat transfer analysis in the fluid pathway
We investigated the heat transfer in the fluid pathway inside the chip holder block of
the fixture design by performing COMSOL simulations. The heating element is placed
inside this block, at the temperature of 37 ◦C. After placing the heating element, we
allow a few minutes for the temperature of the block to reach the target value by
utilizing a heating sensor, before starting the experiment.
Figure 4·3: side-way cross-sectional view of the chip holder block with
the dashed lines showing the fluid pathway inside.COMSOL simulation
for heat transfer analysis from the heated block (at 37 ◦C) to the fluid
inside (at 25 ◦C).
Figure 4·3 shows a side-way cross-sectional view of the chip holder block with the
tube fitting. The black dashed lines emphasize the border of the fluid pathway inside
the block before reaching the O-ring and the inlet of the assembled fluid chamber.
We preformed a simplified COMSOL simulation by considering the fluid pathway as
a direct line.
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The results of this simulation is shown in figure 4·3 with assuming laminar flow in
the pathway. In this plot, we simulated the heat transfer from the heated block (set
at 37 ◦C) to the fluid (set at room temperature, 25 ◦C), entering from the left side of
the block where the inlet is considered. As observed, even with considering laminar
flow, the fluid temperature reaches close to 37 ◦C. It is important to note that in the
bacteria flow experiments for AST analysis, we have a stop-flow mechanism, therefore
giving the fluid inside the pathway plenty of time to reach the temperature of the
block before entering the fluid chamber and the sensor surface.
4.2.4 Image analysis for bacteria growth rate estimation
We perform real-time imaging of the flow chamber with 15 second time interval using
Micro-Manager software throughout the whole assay procedure. We then developed
a custom image analysis MATLAB algorithm based on the image segmentation algo-
rithm detailed here [hyphens]breakurl (Image Analyst, 2021).
Figure 4·4 describes the work flow of the image analysis algorithm: 1- the input
tiff file is cropped to the region around a captured cell on the sensor surface (region
is specified by the user). The reason for this step is to expedite the analysis time
by working with a smaller input image instead of the original raw tiff file from the
whole FOV. 2- The next step generates a binary image by applying a threshold value
to the cropped image to remove the additional background. 3- Next, based on two
selection parameters pre-adjusted by the user, the detected blob region which meets
the selected criteria, is chosen in the input image and separated from the additional
particles in the image. These selection parameters are simply based on the average
pixel intensity and the surface area of the detected blob regions in the input image. 4-
Finally the surface area of the selected cell is extracted based on the number of pixels
located in the target cell region in the input image. This analysis is performed for the
all time frames of the input image, acquired throughout the bacteria growth assay.
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In this figure the analysis steps are shown at time frames t1, t2, and t3, corresponding
to initial time of capture, middle of growth assay and at the end of the assay, right
before division.
Figure 4·4: Image analysis algorithm steps for tracking the bacte-
ria cell surface area including: 1- cropping the original image to the
area around the captured cell. 2- applying threshold value to generate
a binary image. 3- target selection based on the user defined input
parameters (the average pixel intensity and the surface area size). 4-
extracting the surface area of the detected target cell at each time frame
based on the number of pixels.
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4.3 Results and discussion
4.3.1 Cell surface area tracking throughout growth assay
As described in the image analysis algorithm, the calculated cell surface area of the
target cell at each time fame will be a data point in the output plot of the algorithm
shown in figure 4·5. The data points in this plot correspond to the surface area of
the E. coli cell shown in figure 4·4 at different time frames.
The red window on the plot shows the lag phase of the bacteria where no increase
in the cell surface area was observed. The lag phase is defined as the initial period it
takes for the bacteria cells to adjust to their new environment (from broth suspension
to the chip surface), before starting their growth (Bertrand, 2019).
Figure 4·5: Cell surface area (in pixels) as a function of the time
frame number during the bacteria growth assay. The red window cor-
responds to the lag period it takes for the target cell to adjust to its
new environment and no growth was observed.
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4.3.2 Bacteria lag period estimation
In order to estimate the lag period for target cells, a linear fit analysis is performed
on the data points shown in figure 4·5. The algorithm first goes through a repeating
loop which divides these cell surface area data points to two time frame categories,
locating before and after each selected data point. The plot in figure 4·6a describes
this division schematically, with two example selected data points shown with red
and green pointers, and the brackets on either side showing the two data categories
for linear fit analysis. This analysis is repeated for all time frames.
(a) (b)
Figure 4·6: (a) cell growth data point division schematic, with red
and green pointers showing two example selected data point. The two
brackets on either side of the pointers show the data set categories
for linear fit analysis. (b) The maximum slope difference between the
two linear fits based on the time frame number of the selected data
point. the red line shows the maximum slope difference frame number
corresponding to the lag period of the target cell.
Next, for each linear fit analysis loop, the difference of the slope of the two fitted
lines is calculated. The lag period is chosen at the data point which generates the
maximum slope difference between these two fitted lines. For a faster analysis outcome
from the algorithm, we limit the range of data points for which the linear fit analysis
is performed. Initially a visual inspection of the cell growth plot is performed by
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the user to have an estimation of the break point. Therefore instead of running the
analysis on all data, we input only a limited range of these data points around the
estimated break point from the visual inspection.
The plot in figure 4·6b shows the maximum slope difference between the two
linear fits based on the time frame number of the selected data point. As observed,
the linear fit analysis here was performed only for the time frame range of 50-150,
with the maximum slope difference occurring at the frame number 62, shown with
the red line in this plot, corresponding to the lag period of this cell.
4.3.3 Bacteria growth rate estimation
Image-based bacteria cell growth rate estimation is based on the cell surface area
increase during the real-time monitoring of the captured cells (Choi et al., 2013;
Zhang et al., 2020; Choi et al., 2017). Equation 4.1 describes the calculation of
growth rate (µ) based on the cell surface area at initial time (t0) of capture (S0) and




) = µ× (t− tm) (4.1)
Finally, after the lag period estimation (tm), the bacteria growth rate is calculated
based on the equation 4.1. The two red lines in figure 4·7 show the fitted lines to the
cell area data points, before and after the lag period frame number (number 62 in
this example) calculated in the previous section, shown with the vertical purple line.
The cell surface area at time t0 and t (end of the growth assay) are calculated from
the linear fit equations and the time frame numbers are converted to the time unit
(hr) based on the 15 seconds interval between image acquisition frames. The inset
in this plot shows the equations of the two linear fits and the calculated growth rate
(hr-1) from the equation 4.1.
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Figure 4·7: Cell growth rate estimation based on the increase in the
cell surface area during the growth assay time. The purple line shows
the lag period of the target cell and the two red lines show the fitted
lines to the data points before and after the lag period frame number.
The equations of the fitted lines and the calculated growth rate is shows
in the inset of the plot.
4.3.4 Tracking bacteria growth and division cycles
In addition to tracking the bacteria growth, we are also able to observe bacteria
division during the growth assay for the faster growing cells in our sample. The
bacteria cell division occurs when a single cell grows to twice its initial size, at which
point cell division occurs and the original cell is divided into two identical daughter
cells. The plot in figure 4·8 shows the cell area (pixels) increase based on the assay
time (minutes), which undergoes 4 growth and division cycles.
The inset at the bottom of the plot, shows the images acquired from the target
cell at its initial and right before division time for each division cycles. The red
pointers show the time frame to which the shown cell images correspond in the plot.
As observed, after the division of the original cell to two daughter cells, one of them
remains attached to the sensor surface (from the end it was attached to the surface
in the original cell) and the newly generated one gets released into the fluid chamber.
This allows us to track the individual bacteria growth rate in each cycle. The re-
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maining cell on the sensor surface which will go through the next growth and division
cycles is shown with the yellow circles in the inset.
Figure 4·8: Tracking bacteria growth and division cycles. The plot
shows the cell area increase based on the assay time.
Taking a closer look at the time it takes for the target cell to grow and divide
in each cycle, we observe an average division time of 24 minutes between the cycles
for this example cell. This value closely matches the theoretical expected value for
the E. coli division time which is estimated to divide every 20 min in the laboratory
nutrient-rich conditions (Gibson et al., 2018; van Heerden et al., 2017).
In addition, we would like to point out that we also observed filamentation in some
of the captured E. coli cells on our sensor surface (such as the first image in the inset
of figure 4·8). Filmanetation occurs when anomalous growth of certain bacteria, such
as E. coli, is observed in which case the cell continues to grow and ceases to divide
(Justice et al., 2006).
These elongated cells in fact have multiple chromosome copies (Jaimes-Lizcano
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et al., 2014). Filamentation has been found to be a defense mechanism of the bacteria
as a response to the environmental stresses such as heat, antibiotic agents, oxidative
damage, and limited nutrition (Hahn et al., 1999; Guo and Gross, 2014).
4.3.5 Bacteria growth rate distribution
As discussed earlier, our biosensor enables us to monitor and track the changes of the
cell size for all the captured cells on the sensor surface in our FOV. The histogram in
figure 4·9 shows the distribution of the number of cells based on the calculated cell
growth rate. The growth rate of zero corresponds the case where no increase in the
cell surface area is observed.
Figure 4·9: Histogram of the bacteria growth rate distribution in the
studied population of cells. The insets show time lapse images of two
example E. coli cells throughout the growth assay, which show growth
rates of 1 and 2.5 (hr-1).
For the cells which go through multiple growth and division cycles, we treat
each cycle as a separate data point in our histogram. As discussed in other stud-
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ies (Robazza et al., 2016; Baranyi and Pin, 1999; Sternberg et al., 1999), we observe
the expected normal distribution of the growth rate in our studied cell population.
The insets in this plot show a time lapse of the acquired images from two E. coli
cells corresponding to the growth rate of 1 and 2.5 (hr-1). The time lapses are showing
the image of the cell at the initial time of capture, middle of the growth assay and
finally at the end of the assay.
4.3.6 Antibiotic effect on growth rate and AST analysis
We have shown in the previous section that we are able to track the growth rate of the
bacteria population during growth assay. Next, we repeated the same experimental
procedure, to investigate the effect of adding antibiotics to our fluid chamber at
various concentrations on the bacteria growth rate.
Here, we have chosen to study the effect of the antibiotics ampicillin and gentam-
icin on E. coli. We selected two concentrations for these antibiotics which are above
and in the MIC range levels. The studied concentrations for gentamicin are 1 and 100
µg/ml (MIC = 0.25 - 1 µg/ml). The results of this study is shown in the histogram
plot of figure 4·10 comparing E. coli growth rate distribution at various introduced
antibiotic challenges with the normal growth assay in the absence of any antibiotic
agent (previously shown in figure 4·9)
The insets of this plot show the time lapse images of two E. coli cells which
have been exposed to the antibiotic gentamicin at concentrations of 1 and 100 µg/ml
corresponding to the bacteria growth rates of - 0.1 and - 0.3 (hr-1).
As expected, for the concentration of 1 µg/ml, which is in its MIC range for E.
coli, the bacteria growth is halted and the cell surface area stays relatively constant
throughout the assay. However, for the gentamicin at concentration of 100 µg/ml,
added to the bacteria sample mix, we observe negative growth rate resulting in bac-
teria cell surface area decrease as shown in the time lapse images.
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Figure 4·10: Histogram of the bacteria growth rate distribution in the
studied population of cells under three antibiotic gentamicin challenges:
no antibiotic, added gentamicin at 1 µg/ml and 100 µg/ml. The insets
show time lapse images of two example E. coli cells, which show growth
rates of -0.1 and -0.3 (hr-1), corresponding to added gentamicin at 1
µg/ml and 100 µg/ml.
Figure 4·11 shows the same analysis results for the antibiotic ampicillin at con-
centrations of 5 and 500 µg/ml (MIC = 2 - 8 µg/ml) compared to the normal growth
assay distribution.
The insets in this plot correspond to time lapse images of two cells with growth
rates of - 0.1 and - 0.2 (hr-1) for the added ampicillin concentrations of 5 and 500
µg/ml. The same as the case for gentamicin, we see no growth for the ampicillin
concentration in the MIC range, compared to the shrinking E. coli cells throughout
the assay with added ampicillin at concentration of 500 µg/ml.
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Figure 4·11: Histogram of the bacteria growth rate distribution in the
studied population of cells under three antibiotic gentamicin challenges:
no antibiotic, added ampicillin at 5 µg/ml and 500 µg/ml. The insets
show time lapse images of two example E. coli cells, which show growth
rates of -0.1 and -0.2 (hr-1), corresponding to added ampicillin at 5
µg/ml and 500 µg/ml.
4.4 Summary
In this chapter we have explored the application of our developed optical biosensor
for rapid image-based AST analysis. the shortcomings of the common culture-based
AST methods, currently practiced in clinics, have initiated concerted research effort
for developing new methods for rapid AST analysis.
The advantages of our developed biosensor have prompted us to utilize it for
addressing these limitations by performing rapid image-base AST analysis. The key
advantages of this biosensor playing a crucial role for this application include, label-
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free capture and visualization of the target pathogen, combination of a large FOV
with single-cell optical resolution, and integration of our biosensor with microfluidic
channel for in-liquid imaging of the sensor surface in real-time.
Here, we have successfully demonstrated the ability of our biosensor to visu-
alize, monitor, and dynamically quantitate the surface area of individual bacterial
pathogens captured on the sensor surface. As shown in our results, the exposure of
susceptible bacteria to various antibiotics agents, here gentamicin and ampicillin, can
trigger a distinct change in growth rates of pathogens. In addition, as demonstrated
in our results, we were able to monitor multiple cycles of cell growth and division for
the faster growing cells. This allows us to also study the division characteristics of
the target bacteria for specific applications.
In this study we have focused on AST analysis for E. coli bacteria which is one
of the leading causes of resistant infections for which a rapid diagnostic could be
immediately useful. However, the sensor surface could be functionalized with different
capture probes specific to various target pathogens depending on the application.
In addition, our developed image analysis algorithm is capable of estimating the
bacteria lag period and growth rate for every captured cell on the sensor surface. Our
biosensor’s performance in rapid AST analysis was demonstrated by comparing the
growth rate distribution of the studied bacteria population under various antibiotic
challenges to its normal growth distribution without the presence of any antibiotic
agent. Therefore, the combination of automated image acquisition and image analysis,
fluidic system integration, and cost-effective optical instrument offers a rapid and




5.1 Summary of the thesis
In this dissertation, we described the design and development of a rapid, sensitive, and
multiplexed sensor platform for detection of pathogenic bacteria as well as assessing
their susceptibility to various antibiotics by imaging and monitoring the growth rate
of individual bacteria. The current common clinical methods for bacteria detection
and susceptibility testing are separate, culture-based assays that are inherently time-
consuming. The limitations of the current techniques have sparked significant interest
in the field of biosensor development, with considerable attention to optical biosensors
for label-free whole-cell bacteria detection. SP-IRIS is a promising tool for sensitive
and rapid target detection which has been used previously for detection of various
biological targets. Here, we built upon the SP-IRIS platform and utilized it for
pathogenic bacteria identification and AST analysis. The simple and low-cost design
of our biosensing platform makes it a perfect candidate as a clinical POC diagnostic
tool.
In chapter 2, we described the design and implementation of the optical setup,
as well as the custom-developed particle detection algorithm, for rapid and sensitive
whole-cell bacteria detection with end-point measurement. Taking advantage of the
dual imaging modality of our biosensor in this study, we were able to perform target
detection and characterization by switching the imaging magnification and validate
the functionality of our particle-detection algorithm. We successfully demonstrated
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rapid and sensitive E. coli detection in PBS and tap water, as well as the biosensor’s
specificity against other non-target bacteria.
This study laid the groundwork for developing the real-time detection modality
of this biosensor described in chapter 3. In chapter 3 we first introduced the three
key improvements applied to our biosensor for kinetic measurements of the target
binding event on the sensor surface, compared to the end-point measurement in the
previous chapter. These improvements were: 1) biosensor design integration with a
microfluidic flow cell with an AR-coated glass window allowing for imaging of the
sensor surface during the bacteria capture. 2) improving the sensor surface capture
efficiency by utilizing DDI-based immobilization of antibody probes, demonstrating
a more sensitive and robust detection assay compared to direct immobilization of
antibodies. 3) optical setup design improvement, enabling us to perform bacteria
detection and shape characterization in a single field-of-view of the imaging system.
We demonstrated real-time in-liquid E. coli detection through both heterogeneous and
homogeneous DDI-based assays enabling a reconfigurable bacteria detection platform.
In chapter 4, we focused on application of our biosensing platform as a rapid and
sensitive image-based AST analysis tool. In this chapter, we discussed the necessity
for development of a new AST tool in clinical setting that could produce timely test
results as opposed to the current time-consuming culture-based methods. We also
provided a detailed description of the applied modifications to the optical setup for
providing the optimal condition for bacteria growth, as well as our image analysis
MATLAB algorithm for tracking cell surface area changes in various antibiotic condi-
tions. The functionality of our AST analysis tool was validated by performing rapid
susceptibility testing of E. coli to ampicillin and gentamicin, by tracking the bacteria
growth rate distribution.
As presented in this dissertation, the integration of rapid and sensitive bacte-
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ria detection and characterization with AST analysis in a single instrument would
greatly improve the mortality and morbidity rate for patients with bacterial infec-
tion by timely diagnosis of the bacterial infection and the optimal antibiotic therapy
determination. We strongly believe that the outcome of this study could provide
significant contribution to biomedical research and clinical diagnostics and will have
great impact in the field of pathogenic bacteria detection and AST analysis.
5.2 Future Directions
5.2.1 Microarray printing optimization for maximum target capture
One of the most important considerations in biosensor optimization is being able
to detect very low concentrations of target analyte in the least amount of time. In
order to do so, we should utilize as much available space as possible on the sensor as
a functional surface for capture probe which in turn would increase the probability
of the target binding to the surface and therefore being detected at the end. This
requirement has led us to investigate a spotting pattern design which is rather easy
and time efficient and at the same time would let us use more available surface of the
chip surface for capture probe immobilization.
Figure 5·1a shows the sensor surface image, acquired before bacteria sample incu-
bation, functionalized with the first iteration of spotting recipe. This spotting design
includes three columns of capture antibody and one column of negative control, re-
peated throughout the sensor surface. Next as shown in figure 5·1b, we implemented
and optimized spotting design which performs a second spotting round at the empty
spaces between the existing microarray spots in the first design.
By comparing the same region of IRIS chip shown in figure 5·1a and figure 5·1b,
we observe that we are able to increase sensor surface coverage with the target capture
probes by more than %50 (the number of antibody spots increased from 16 in the
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first round to 36 in the second round of spotting).
(a) (b) (c)
(d) (e) (f)
Figure 5·1: Images of the microarray spotted sensor surface, before
bacteria sample concentration, with the (a) first iteration of spotting
recipe. (b) optimized spotting recipe for increasing surface coverage
with capture probe. (c) image of the sensor surface after incubation,
confirming increased capture capacity of the sensor in the current FOV
in one setting.(d)-(f) potential capture probe spotting designs proposed
for future studies.
As shown in figure 5·1c, we then confirmed the enhanced target capture capacity
of the same area of our sensor surface, by incubating this IRIS chip in the bacteria
sample, where the black dots on the antibody spots indicate the captured E. coli cells
on the sensor surface.
We believe that the microarray spotting optimization could be further enhanced
by investigating other spotting designs to achieve more capture probe coverage on
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the sensor surface. Figures 5·1d-f show a few spotting designs which we propose as
potential future direction of this study.
It is important to note that in addition to the functional implementation of these
spotting designs, there are other consideration one should also take into account. For
example, one critical consideration is making sure that the capture probe binding
functionality is not affected by the spotting mechanism, such as folding or self-dimer
structure for the DNA immobilization.
The designs in figures 5·1d and 5·1e can be implemented with the line spotting
mechanism already utilized in commercial robotic spotters. One could also consider,
dispensing 100s of droplets on one spot (instead of a few droplets in the standard
spotting recipe) to achieve a much larger capture spot in the FOV, shown in figures
5·1f.
5.2.2 microfluidic channel optimization
As described in detail in chapter 3, currently the microfluidic channel is built by the
single channel spacer layer. We have shown that a multiplexed target detection could
be performed on our biosensor by functionalizing the sensor surface with various
capture probes. We can further improve our biosensor functionality by utilizing a
multi-channel ow chamber on a single IRIS chip with modified spacer and fixture for
multi-channel liquid handling.
Therefore, we can perform multiple analyte detection experiments in parallel,
simultaneously which will decrease our detection assay time by multiple orders by
running several experiments in one setting. Figure 5·2 shows a potential design for a
2-channel flow chamber placed along at the short edge of the spacer (We could also
use the longer edge to fit a 4-channel ow path).
This improvement could play a crucial role for AST analysis studies described in
chapter 4. For determining the MIC level of an antibiotic agent against a pathogenic
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bacteria, having a high-throughput analysis tool could prove significantly useful for
acquiring a timely analysis outcome. The multi-channel flow chamber provides the
opportunity to investigate the bacteria growth rate changes under various antibiotic
challenges, simultaneously.
Figure 5·2: Design of the spacer layer for a 2-channel flow chamber
for performing simultaneous measurements in each channel.
For example, as a model experiment, a nutrient-rich bacteria sample could be first
incubated with the multi-channel IRIS chip. Once the bacteria cells are captured
on the sensor surface, we can introduce different broth solutions with prescribed
concentrations of antibiotic to each flow channel for a comparison with the antibiotic
free reference channel, while performing real-time monitoring of the captured cells.
It is also important to mention that even if our optical FOV does not cover all the
flow channels at once, we can easily scan the sensor surface without losing any data,
since the images are acquired every 15 seconds.
5.2.3 optical setup design improvement for high-throughput AST analy-
sis
The design flexibility of our biosensor, enables us to integrate it with a 96 well plate
for sensor incubation instead of the fluid chamber assembly and chip holder used
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in the current design described in this thesis. The schematics of this new design is
shown in figure 5·3 which will be especially useful for high-throughput AST analysis
studies. The design has already been patented in our group and we encourage the
interested readers to refer to this patent (Unlü et al., 2020) for more details on the
design implementation.
Figure 5·3: SolidWorks modified design of SP-IRIS instrument for
micro well plates with a 96-well and imaging through the bottom of the
well plate. The inset shows the details of the chip holder for locating
the IRIS chips inside each well containing different clinical samples.
As shown in the inset of figure 5·3 each base of the sample holder, will hold the
IRIS chips (the 10 mm × 10 mm square version) immersed in the existing samples
in each well, while maintaining the chip at a flat plane for properly focused imaging
through the objective located at the bottom of the well plate.
With implementing this new design, our biosensor will be able to run simultaneous
AST analysis for multiple patients’ samples and different antibiotics in a rapid, mul-
tiplexed and user-friendly platform. This could be achieved by automatic scanning
of the 96 well plate, with each well containing a different clinical sample.
Development of rapid, sensitive, and reliable POC biosensor systems has impor-
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tant implications for food and water industry as well as improving patient care,
providing rapid testing ability in bacterial infections and contaminations. In this
dissertation we demonstrated the capability of SP-IRIS for bacterial detection and
antibiotic susceptibility determination through single-cell bacteria imaging and their
growth rate tracking. We strongly believe that our technology will have a great impact





In order to optimize the antibody concentration for best microarray printing outcome,
we printed antibody spots on the funtionalzed IRIS chip at different concentrations.
The left panel in figure A·1 shows the image of an IRIS chip (acquired with objective
5X/0.15 NA) with the antibody microarray printed at concentrations of 0.5 mg/ml,
1 mg/ml, 2 mg/ml, and 3 mg/ml, as described in the figure inset. The plot in figure
A·1 shows the height profile of the microarray printed sensor surface, along the black
dashed line on the IRIS chip image. we observe that at lower concentrations, the
antibody spots are not completely formed and we get inconsistent spot morphology.
Figure A·1: Antibody concentration optimization for spotting
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Next, to perform an analytical inspection for the quality and repeatability of
the antibody spotting process throughout different chips, we developed a custom
MATLAB algorithm to compare the average height of the antibody microarray spots
in multiple chips. Figure A·2a describes step 1 of this algorithm functionality, where
the sensor raw image (with printed microarray) and the mirror images (bare silicon
chip) are inserted as the inputs. The output of this steps, is a matrix with dimensions
equal to the number of pixels in the original image, where each element of the matrix
corresponds to the height of each pixel relative to the background.
Figure A·2b shows the analysis process in step 2 of the algorithm, which accepts
the generated matrix from step 1 as the input. In the next three sections of the
analysis: 1- the input matrix is converted to a binary matrix by applying a proper
threshold value, 2,3- the additional structures (except the microarray spots) in the
matrix are eliminated in each row and column between the microarray spots, respec-
tively. These additional structures are a result of existing mask features on the chip
surface, dirt particles, and random spotting errors. In order to extract the height
values of the spots in the original image, the algorithm first has to recognize the
location of the spots. After removing these additional features, now the algorithm
can basically recognize the elements in the matrix with values 1 compared to the 0
background (so each spot is showing up as a colony of several connected elements in
matrix which all have value of 1). Finally the remaining spots in the image are color
indexed as the result of recognizing these colonies and indexing them from 1 all the
way to 49 in the example image shown here (looking at the image, we have 49 spots
on this chip). So, we are able to count the number of spots in the image and finally
this will make it much easier for the algorithm to access each colony ( ex: colony
1, colony 2, ..,colony 49) and replace the 1’s in each spot with their corresponding




Figure A·2: MATLAB algorithm functionality for analytical inspec-
tion of the quality and repeatability of the antibody spotting process.
(a) step 1 of the algorithm to produce the height matrix from the in-
put raw image of the chip. (b) step 2 of the algorithm to remove the
additional features in the matrix and acquire the final height matrix.
Once the final height matrix corresponding to each antibody spot is acquired, we
can compare the antibody spots’ homogeneity and repeatablity in different chips. In
order to do so, we spotted three IRIS chips with E. coli antibody at concentrations
of 1.5 mg/ml and 3 mg/ml, and BSA at 1 mg/ml as negative control, shown in
figure A·3a. We next, performed the analysis detailed previously for all spots in the
microarray to acquire the height values for each condition. The plot in figure A·3b
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shows the average height for each spotting condition throughout the microarray as a
function of the column number on each IRIS chip. the error bars of each data point
show the standard deviation from the average height value for that condition and the
three plots with colors blue, green , and purple correspond to the analysis results for
IRIS chips 1 to 3, respectively. 3.0 mg/ml was found to be the optimum antibody
concentration for spotting which yielded the best spot morphology and homogeneity




Figure A·3: (a) Raw image of three IRIS chips with spotted microar-
ray. (b) average height for each spotting condition as a function of the
column number on each IRIS chip.
References
(1996). Introduction to Bacteriology. In Baron, S., editor, Medical Microbiology.
University of Texas Medical Branch at Galveston, Galveston (TX), 4th edition.
Ahmed, A., Rushworth, J. V., Hirst, N. A., and Millner, P. A. (2014). Biosensors for
whole-cell bacterial detection. Clinical Microbiology Reviews, 27(3):631–646.
Anderson, M. J., Miller, H. R., and Alocilja, E. C. (2013). PCR-less DNA co-
polymerization detection of Shiga like toxin 1 (stx1) in Escherichia coli O157:H7.
Biosensors and Bioelectronics, 42:581–585.
Arora, P., Sindhu, A., Dilbaghi, N., and Chaudhury, A. (2011). Biosensors as innova-
tive tools for the detection of food borne pathogens. Biosensors & Bioelectronics,
28(1):1–12.
Aryal, S. (2019). Spread Plate Technique- Principle, Procedure, Advantages (https://
microbenotes.com/spread-plate-technique/). Microbe Notes.
Avci, O., Adato, R., Ozkumur, A. Y., and Ünlü, M. S. (2016). Physical modeling of
interference enhanced imaging and characterization of single nanoparticles. Optics
Express, 24(6):6094–6114.
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Unlü, M. S., Sevenler, D., Trueb, J., AVCI, O., Yurdakul, C., Scherr, S., Daaboul,
G. G., and Freedman, D. S. (2020). Systems and methods for imaging microwell
plate samples. US patent US10585042B2.
van Heerden, J. H., Kempe, H., Doerr, A., Maarleveld, T., Nordholt, N., and Brugge-
man, F. J. (2017). Statistics and simulation of growth of single bacterial cells:
illustrations with B. subtilis and E. coli. Scientific Reports, 7(1):16094.
Velusamy, V., Arshak, K., Korostynska, O., Oliwa, K., and Adley, C. (2010). An
overview of foodborne pathogen detection: in the perspective of biosensors. Biotech-
nology Advances, 28(2):232–254.
Wacker, R. and Niemeyer, C. M. (2004). DDI-FIA—A Readily Configurable Mi-
croarray Fluorescence Immunoassay Based on DNA-Directed Immobilization of
Proteins. ChemBioChem, 5(4):453–459.
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